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COMPARING THE EFFECTIVENESS OF THE VIDEO LARYNGOSCOPE WITH
THE DIRECT LARYNGOSCOPE IN THE EMERGENCY DEPARTMENT:
A META-ANALYSIS OF THE PUBLISHED LITERATURE
D. SEAN DEGARMO, MSN, RN

Abstract
Purpose: Rapid intubation is essential for the critically ill patient in the emergency
department (ED) to ensure adequate oxygenation. Regardless of presenting illness or
injury, the first pass success rate (FPS) can impact patient morbidity and mortality. The
aim of this study was to evaluate the FPS of video laryngoscopy (VL) compared with
direct laryngoscopy (DL) in adult patients intubated in the ED. Methods: Ovid Medline,
Cochrane Library database, Embase, and Google Scholar were searched for peerreviewed articles on studies of human subjects reporting a comparison of FPS rates
between VL and DL in adult patients who were orotracheally intubated in the ED. A
meta-analysis was performed using odds ratio (OR) as the summary effect measure for
FPS. A pooled effect size with 95% Confidence Interval (CI) was calculated using a
random effect model with the inverse weighted method. Results: 8,428 intubations (2,588
VL and 5,840 DL) from nine studies (five observational and four randomized control
trials) were included in the sample. The pooled OR for first pass success across all studies
was 1.89 [95% CI 1.17-3.07, p< 0.01], favoring VL when compared with DL. The results
were limited by potential bias (selection and performance) and high levels of
heterogeneity [I2 = 88%; 95% CI: 79%-93%; Q = 64.61; p< 0.01]. Conclusions: Threats
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to validity made it difficult to conclude with certainty that one device is better than the
other for achieving a successful intubation on the first attempt in the ED.
Keywords: emergency, intubation, video laryngoscopy, meta-analysis
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Summary of Study
On January 26, 2016, “Comparative and Cost Effectiveness Analysis of the
Video Laryngoscope” was approved by Center for Protection of Human Subjects (CPHS)
at the University of Texas Health Science Center – Houston (UTHSC-Houston) HSL-SN16-0032 (Appendix A). The study was planned to use existing data from a database. On
September 12, 2016, Baylor IRB gave approval. H-39327 – “Comparative and Cost
Effectiveness Analysis of the Video Laryngoscope” (Appendix B - Approval from Baylor
College of Medicine IRB).
After one year of attempting to access the data, the data were unattainable due to
unforeseen circumstances. The dissertation committee was reconvened on December 6,
2016, and they decided that a systematic review of the literature should be performed. A
meta-analysis may also be required to determine a first pass success rate from the
published literature. On February 28, 2017, a protocol change request was granted from
CPHS (Appendix C - Change approval from CPHS).
While performing the systematic review of the literature, it became apparent that
there was a difference between studies. The principal investigator (PI) met with the
dissertation chair and discussed with committee members that a meta-analysis would
need to be performed to address the comparative effectiveness to calculate an effect size.
They agreed that this change in methodology needed to occur so that the AIM 1 could be
adequately addressed. The PI had experience and training in performing systematic
reviews, but limited exposure to performing a meta-analysis.
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The PI completed an online systematic review and meta-analysis course in metaanalysis authorized by Johns Hopkins University and offered through Coursera
(Introduction, 2107). To further assist in understanding and experiencing meta-analysis,
the author attended a professional development and training extended course on advanced
meta-analysis at the April 28, 2017 annual meeting of the American Educational
Research Association (AERA). The course, PDC12: Advanced Meta-Analysis was taught
by Terri D. Pigott, Loyola University Chicago; Joshua R. Polanin, Development Services
Group; Ryan Williams, American Institutes for Research; and Ariel M. Aloe, University
of Iowa (2017).
After attending the course, a meta-analysis of the published literature was carried
out. A meta-analysis is an extension of the systematic review process. It is the statistical
procedure for combining data from multiple studies to calculate a ‘standardized effect
size’ that summarizes the effect sizes across all of the studies that met the inclusion
criteria for the review. The additional steps performed were a quality evaluation (See
Table 3A and 3B), data analysis, heterogeneity examination, assessing publication bias,
and interpretation and reporting of the results.
The PICOS format was used for the research question to be consistent with
studies in the literature: Among adults emergently intubated in the Emergency
Department, does Video Laryngoscopy (VL) have a higher first pass success rate
compared with Direct laryngoscopy (DL)?
a. Population- is Adults emergently intubated
b. Intervention- is Video laryngoscopy
c. Control- is Direct laryngoscopy

3
d. Outcome- is the first pass success rate
e. Setting- is the Emergency Department
The research question was not able to be answered due to the significant
heterogeneity that prevented appropriately combing these studies. The difference between
studies was not due to happenstance. Even with the risk of bias found in the RCTs, there
remained acceptable heterogeneity. However, there was no accounting for excessive
variation in the observational studies. This variation was most likely a confounder that
was controlled for randomized studies.
The conclusion of the meta-analysis was that there was no way to answer the
research question with certainty due to the heterogeneity and high risk of bias. A cost
effectiveness analysis (AIM 2) could not be performed due to the heterogeneity and bias
effect, summary effect measurement and the lack of reported adverse events reported.
The dissertation chair and committee members agreed that continuing to perform a cost
effectiveness analysis was not possible. It was, therefore, recommended that it be part of
a future study post-graduation.
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Original Proposal

Specific Aims
AIM 1: Determine the comparative effectiveness among matched patients from
the Baylor/Ben Taub ED database using VL compared to those using DL regarding the
first pass success rate as the measurement of “effect.”
Hypothesis: The VL will have a higher first pass success rate than the DL.
AIM 2: Estimate the incremental cost effectiveness ratio (ICER) using the first
pass rate as the “effect” measurement while controlling for the amount and type of DACs
comparing the VL to the DL in the ED from the perspective of the ED administration in
matched patients.
Research Strategy
Significance.
Intubation indications. Intubation of the critically ill or emergent patient in the
ED is complex and associated with variables that can impact the patient’s morbidity and
mortality regardless of the presenting injury or illness (Table 2). It is estimated that there
are 267,750 patients intubated annually in the United States (Weingart, Carlson,
Callaway, Frank, & Wang, 2013). The most common indications for intubation in the ED
for medical emergencies are cardiac arrest, drug overdose and congestive heart failure
(CHF). Head trauma is the leading indication for intubation in the trauma patient (Walls,
Brown III, Bair, & Pallin, 2011). Rapid intubation is essential to ensure adequate
oxygenation, yet up to 26% of these patients will experience complications related to
intubation difficulty, such as multiple attempts, prolonged periods without ventilation,
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and esophageal intubation (Nable et al., 2012; Sakles et al., 1998; Wang & Yealy, 2006;
Wayne & McDonnell, 2010; Wong & Ng, 2008).
First attempt success. Success on the first attempt is defined as the proper
placement of an endotracheal tube on the initial attempt (Mosier, Stolz, Chiu, & Sakles,
2012; Sakles & Kalin, 2012). The success rate of the first attempt at intubation is critical
because multiple attempts to increase the likelihood of adverse events (AEs): airway
trauma, aspiration, dysrhythmias, hypoxemia, anoxia, brain injury or even death (Jaeger
et al., 2000; Nable et al., 2012; Sakles et al., 2013; Wang & Yealy, 2006). The likelihood
of AEs to occur more than triples from the first attempt (14.2%) to the second attempt
(47.2%) (Sakles et al., 2013).
Difficult intubation. A difficult intubation has been defined as a situation in
which an airway that cannot be securely intubated using standard methods with multiple
attempts (Bair, Filbin, Kulkarni, & Walls, 2002) by a traditionally trained
anesthesiologist (Apfelbaum et al., 2013). Difficult intubations have been reported to
occur in a range of 4% to 26% of all intubations performed in the ED (Sakles et al., 1998;
Wong & Ng, 2008). The difficulty of the intubation is associated with patient
characteristics, the setting, skill, and experience of the clinician (Apfelbaum et al., 2013).
In some cases, a difficult intubation can be anticipated before the initial attempt (Bair et
al., 2002; Walls & Murphy, 2008). Unfortunately, there are a significant number of cases
in which the intubator may not be able to determine if the intubation is difficult until he
or she is making an attempt (Bair et al., 2002; Walls & Murphy, 2008).
Difficult Airway Characteristics (DACs). Several patient characteristics
associated with preventing the alignment of the oropharyngeal axes make successful
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intubation more difficult or impossible (Mosier, Chiu, Patanwala, & Sakles, 2013; Mosier
et al., 2012). These characteristics are termed DACs (Sakles et al., 2014). The DACs
most commonly reported are obesity, large tongue, short neck, small mandible, cervical
immobility, blood, vomit (emesis), airway edema, and facial or neck trauma (Mosier et
al., 2012; Patanwala et al., 2011; Sakles & L. Kalin, 2012). As the amount of DACs
increase, the more likely a difficult intubation will be encountered, which is associated
with a higher rate of hypoxia, esophageal intubation, airway trauma and cardiac arrest
(Mort, 2004).
Measurements to predict a likelihood of difficult airways. Anesthesiologists
often have the ability to perform airway assessment measurements that are useful in
predicting a difficult airway. The most common assessments include the CormackLehane (CL) grading scale and the Mallampati classification (Bair, Caravelli, Tyler, &
Laurin, 2010; Levitan, Everett, & Ochroch, 2004). The CL grading scale was developed
as a visual scale to determine the view of the larynx obtained during direct laryngoscopy
(Appendix A-1). It is measured using a scale of I to IV, where I and II are associated with
intubations that are classified as easy and III and IV are difficult (Cormack & Lehane,
1984). The CL grading system has inferior inter-rater reliability (kappa=0.16) in the
operating room (OR) and the ED (Ochroch, Hollander, Kush, Shofer, & Levitan, 1999).
While the Mallampati classification considers a large tongue that obscures the
oropharynx the most significant predictor of a difficult intubation (Appendix A-2). The
larger the tongue, the more likely the intubation will be difficult. A Mallampati class III
or IV is anticipated to be a difficult intubation whereas a class I or II classification is
predictive of a less challenging intubation (area under the sROC curve = 0.83 ± 0.03)
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(Lee et al., 2006). The Mallampati classification has been demonstrated as helpful in
assessing patients in the preoperative setting. However, in the ED Mallampati scoring
was unobtainable in 75% of patients because it requires a cooperative patient (Bair et al.,
2010).
Adverse Events (AEs). Complications that occur in conjunction with, or as a
result of, intubation are known as adverse events (AEs) (see Table 3). These include
airway trauma, aspiration, dysrhythmias, hypoxemia, anoxia, brain injury or even death
(Hasegawa et al., 2012; Jaeger et al., 2000; Mort, 2004; Nable et al., 2012; Sakles et al.,
2013; Wang & Yealy, 2006). An increase in the number of attempts made is associated
with the likelihood of an adverse event (Hasegawa et al., 2012; Martin, Mhyre, Shanks,
Tremper, & Kheterpal, 2011; Mort, 2004). During the intubation procedure, failure to
intubate is the primary cause of death from an anoxic event in 85% of the cases
(Niforopoulou et al., 2010). Failure to intubate occurs when the primary method used to
secure an airway is not successful, and a secondary method must be utilized (Bair et al.,
2002).
Direct Laryngoscopy (DL). Direct laryngoscopy (DL) was patented in the 1940’s.
This invention was designed to give the intubator a direct view of the glottic opening by
aligning the oral, pharyngeal, and laryngeal axes to visualize insertion of the endotracheal
tube (ETT) (Jephcott, 1984). Visualization of the glottic opening by DL requires line of
sight by alignment of anatomic axes that naturally exist at extreme angles (Mosier et al.,
2013) This obscured view of the vocal cords can create a difficult or failed airway
situation. In some patients, it has been noted that certain patient characteristics are
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associated with preventing the alignment of the axes, making it more difficult or
impossible for a successful intubation (Mosier et al., 2013; Mosier et al., 2012).
Video Laryngoscope (VL). An innovation called the video laryngoscope (VL)
was introduced in 2001 as a means for intubating patients with known or predicted
difficult airways (Chemsian, Bhananker, & Ramaiah, 2014). The VL uses a micro sized
video camera at the end of the laryngoscopic blade (Sakles, Rodgers, & Keim, 2008) that
eliminates the need to align the oral, pharyngeal, and laryngeal axes (Chemsian et al.,
2014). VL showed promise in reducing the number of failed airway attempts (Cooper et
al., 2005; Xue et al., 2007). The VL has demonstrated advantages over direct
laryngoscopy DL. The advantages include: 1) better visualization of the glottic opening
(Brown III, Bair, Pallin, Laurin, & Walls, 2010; Mosier et al., 2012); 2) decreased need to
manipulate the cervical spine when inserting the device, thereby reducing the risk of
further damage to a cervical spine injury (Malik et al., 2008); 3) less lift required to open
and manipulate the jaw reducing the potential for airway trauma (Cooper et al., 2005);
and 4) demonstrated increased first attempt success over traditional direct visualization of
endotracheal intubation (Cooper et al., 2005; Sakles et al., 2014; Sakles et al., 2013).
When comparing the VL to the DL in the ER, the VL has a higher first attempt success
rate than the DL in intubations that were predicted to be difficult (Mosier et al., 2012;
Sakles, Mosier, Chiu, Cosentino, & Kalin, 2012; Sakles et al., 2014).
Setting. VL has been shown to be successful in the OR, especially in cases of
predicted difficult intubation and as a rescue device (Aziz et al., 2011; Noppens et al.,
2010). Anesthesiologists are the experts in intubation and perform the procedure
routinely (Rothfield & Russo, 2012). The experience of the intubator is a variable that has
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been shown to be a predictor in obtaining better laryngoscopic views and success rates
(Graham, Oglesby, Beard, & McKeown, 2004; Kim, Kim, Choi, Je, & Kim, 2013;
Patanwala, Stahle, Sakles, & Erstad, 2011; Sakles & Kalin, 2012; Shah et al., 2011). An
example is demonstrated by the incidence of failed intubation in the ED of 1.5 %, while
the OR is 0.1% (Cook & MacDougall-Davis, 2012). In the OR, a difficult intubation
occurs in 1-4% of patients who have seemingly normal airways. However, this number
increases to at least 10% when an emergent situation is encountered. Patients who are
difficult to intubate in the OR are at higher risk for adverse events ranging from 4.1% to
28% (Martin et al., 2011). The frequency in which the device is used may justify the
added cost of the VL in the OR.
Patient intubation in the ED presents a challenging situation for providers because
of the increased risk of injury to the patient (Cook & MacDougall-Davis, 2012) and
litigious nature of the ED compared to the OR. The OR is unlike the ED because of
situational stressors, high patient acuity, cervical restriction, noise, workforce, poor
oxygen reserves, as well as the necessity to secure an airway in the patient who may or
may not have a known difficult airway, make intubation in the ED more challenging.
The situation is further compounded by physiologic time constraints posed by a
deteriorating patient with the frequent presence of blood and secretions not seen in the
OR (Brown III et al., 2010; Shah et al., 2011). Intubation in the ED is a high risk, lowfrequency procedure where the ED provider does not have the ability to cancel the case
as can be done in the OR (Walls & Murphy, 2008).
Experience does not necessarily predict success. Even anesthesiologists have a
difficult time when intubating outside of the controlled environment of the OR. In
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reviewing patterns of liability associated with anesthesiologist malpractice claims arising
from the management of difficult airways from 1985-1999, 23 of the 179 cases occurred
outside of the OR. All of the 23 cases were associated with brain damage (3 cases) or
death (20 cases). More than half of the cases were settled for an average of $305,000
(range $49,050-$2,010,000 in 1999 U.S. dollars) (Peterson et al., 2005).
Practice guidelines for difficult airway management for anesthesiologists
recommend a VL to be available for the difficult intubation (Apfelbaum et al., 2013). The
Office of the Inspector General reported that 11,007 intubations performed outside of the
OR in Veterans Affairs (VA) facilities with a 12% difficult intubation rate (Stalhandske,
Bishop, & Bagian, 2008). There were four difficult intubations per day, and half of those
were esophageal intubations (Stalhandske et al., 2008). As a result of this report and the
updated guidelines, all VA facilities are required to have a VL immediately available at
all times for intubations outside of the OR (VHA, 2012).
Until recently, due to the impracticalities of obtaining informed consent from the
trial participant, an RCT comparing the VL to the DL was not practical in the ED setting.
However, a group of researchers was successful in obtaining approval from the
institutional review board (IRB) using a delayed consent process and performed the only
RCT to date comparing the VL to the DL in trauma patients. This protocol allowed for
consent to be obtained from the patient (or legal representative) after being intubated
based on the emergently time-sensitive nature as well as the inability of the patient to
provide consent due to the injury or illness related to a state of cognitive impairment. The
authors concluded that there was no statistical difference in the first-pass success rates
between the two devices or influence on mortality between the two groups (Yeatts et al.,
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2013). It is important to note that this study only evaluated trauma patients even though
twice as many intubations are performed for medical emergencies compared to traumatic
injuries (Walls et al. 2011). Furthermore, 25% of the data had to be discarded because
some of the attending physicians did not follow the established protocol (Yeatts et al.,
2013).
To date, a cost effectiveness analysis comparing the VL to the DL in the ED has
not been published. The contribution of the proposed research study will provide decision
makers new information to assist in the decision-making process regarding this new
technology.
The importance of proposed research to health and nursing. The results of this
study may assist the potential adopter in another prospective by looking at justifying the
added cost of the new technology. The results of this study will demonstrate another
method of evaluating new technology using the existing data without having to perform a
time and cost intensive RCT.
Innovation
Although advances in technology can result in considerable improvements in
patient outcomes, use of new technology may create new problems. Given that some
devices are safer and effective than others, it is important to assess the appropriateness
and efficacy of each device in every situation where it is planned to be used (McKay et
al., 2009). The cost has become a critical factor in adopting any new technology that may
benefit patient outcomes. While previous research has examined the effectiveness of the
video laryngoscope in the OR and ED, this study is the first to address the cost
effectiveness (CEA) of implementing this new technology in the ED. A CEA may assist
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in providing evidence that new spending is justified by studies of cost and effectiveness
for new technologies being equal to the gain in patient benefits (Chandra, Jena, &
Skinner, 2011). Furthermore, this study will explore the use of a contextual method with
a clear clinical application for evaluating new technology. The clinical application is a
real-world scenario clinicians face when intubating patients emergently in the context of
the ED. By using existing data, this study provides an alternative evaluation of new
technology without the intensive investment of time and cost associated with the more
traditional RCT. The results of this study may assist ED administrators by determining if
the added cost of this new technology would be offset by cost reduction associated with
improved patient outcomes.
Approach
Research Design.
This study will be a secondary data analysis using retrospective observational data
from a major metropolitan ED using a comparative effectiveness and cost effectiveness
analysis approach (Table 1).
Comparative Effectiveness Research (CER). CER is culminating and synthesizing
substantiation that compares the benefits and harms of new methods or treatments
designed to improve care (Sox & Greenfield, 2009). The purpose of CER is to facilitate
informed decision making on behalf of consumers, clinicians, and policy makers that will
improve health care at the individual and population level. Three elements are key to
CER: direct comparison of effective interventions; studying everyday patients in a “real
world” clinical setting; and identification of clinical characteristics of those patients most
likely to benefit (Sox & Greenfield, 2009). This study will address the three key elements
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by (a) directly comparing the two devices based on the first pass success rate; (b)
studying everyday patients in “real world” clinical setting by using an existing database
that includes all those patients with a limited exclusion criteria (Adults and intubations
done by ED providers); (c) Identify clinical characteristics (DACs) for patients most
likely to benefit.
Cost effectiveness analysis (CEA). The CEA identifies measures and compares
the cost of the health output (effects) achieved by one device with at least one alternative.
Effectiveness is measured regarding physical units of inputs, clinical indicators, and
health outcomes. In this study, effectiveness is measured by the first pass attempt success
rate. The results are calculated and presented in a ratio of incremental costs to
incremental effect. The aim of a CEA is to address the relative (incremental) cost per unit
(ICER) of effect (outcome) between two or more technologies that have a common effect
(Drummond et al., 2005). An effective health care intervention is supported by evidence
that it addresses the question of whether the technology works in the clinical practice
setting instead of in theory or principle (Luce et al., 2010). The indication of
effectiveness will be obtained from an existing database for this study.
Study Population.
The data used in this study comes from a population of critically ill and injured
patients who have received immediate airway protection in the ED over a period of 32
months in a major metropolitan public hospital. Data from a population intubated in the
ED was chosen because when intubating in the ED, AEs tend to occur more frequently
compared to the OR (Cook & MacDougall-Davis, 2012). Because this population has a
higher baseline risk, it will be more cost-effective to treat with an intervention that
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establishes a proportional risk reduction than a subgroup with a lower risk when other
factors being equal (Drummond et al., 2005). Eligible study participants include patients
who were orotracheally intubated in the ED using the VL or the DL and are 18 years old
and older. Nasotracheal and surgical methods of intubation, such as cricothyrotomy,
needle, and tracheostomy will not be included.
The Baylor/Ben Taub ED, an academic, level I trauma center, there are
approximately 110,000 patients treated annually with an average of 2-3 patients intubated
daily. In 2012, the VL to DL ratio was approximately 1:3. An increase in the usage of VL
has been observed over the last two years, bringing the VL to DL ratio closer to 1:1.
There are an estimated 2,000-3,000 intubations that occurred during 2012-2014.
Statistical power and sample size needed. Based on previous studies that report a
higher VL first pass success rate when compared to DL (75%-68%) (Mosier et al. 2012;
Sackles et al. 2012), an estimate of a 7% difference between VL and DL groups will be
considered clinically significant. A sample size of 385 patients per group will be
necessary to achieve a statistical power of 0.80 and a significance level of 0.05. All of
the subjects meeting the inclusion and exclusion criteria would be included to ensure
adequate statistical power.
Data Sources
Data will be abstracted from the Baylor/Ben Taub electronic medical record, Epic
Care, by Dr. Michael Gonzales and Sean DeGarmo in Excel format to an encrypted
portable hard drive. Encrypted data will be de-identified and securely housed in a locked
room and in a locked drawer. Access will only be granted to Sean DeGarmo and Dr.
Michael Gonzales.
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Data Extraction
Prior to the examination and analysis of data, IRB approval will be obtained from
UT CPHS and Baylor College of Medicine’s IRB.
The databank will be searched for all patients who have been intubated using the
video laryngoscope, direct laryngoscope, and the presence of DACs prior to intubation
from January 2012 to August 2015. Data will be abstracted based upon a priori inclusion
and exclusion criteria. DACs for subjects who meet inclusion and exclusion criteria will
be included. Other variables will be collected from the databank including: patient
characteristics; intubator characteristics; adverse events; and effect variables (see Table 2
for detailed explanation).
Cost data for each device will be provided by Baylor/Ben Taub (hospital/ED
administration). Dr. Gonzales has requested that cost data be provided for this study from
hospital administration. The cost variables are displayed in Table 2. Invoices for those
costs will be provided to Dr. Gonzales from the institution.
The most meaningful measure of cost associated with multiple attempts is the
increased cost associated with a greater probability of an AE to occur. Avoiding adverse
events is to be calculated as cost savings. The cost associated with AEs is not expected to
be provided by the institution. Therefore, the Closed Claims Study Database will provide
the cost associated with AEs. The AEs are listed in Table 3 and are also reported in
studies commonly associated with emergency intubation (Brown, et al, 2015; Sakles, et
al, 2013). If cost data for AEs is not granted or is not found in the database, then cost data
obtained from a literature review will be used. If any cost data is missing, then a literature
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review will be conducted to provide a cost range. For those cost data that are not located
in the literature search, an estimate will be made and noted.
Certain costs will be excluded from this study. Reimbursement for the intubation
procedure will be excluded because reimbursement is at the same rate regardless of the
device used. Opportunity cost will be excluded because of the difficult nature to calculate
from the retrospective data.
Due to the nature of the data collection, the analysis does not precisely account
for the total amount of time taken to intubate the patient. Time required by the provider to
perform intubation should be the same because the time to intubate with either device
may deviate only by a few seconds.
Data Analysis
Data will be assessed for completeness. Subjects with data missing values will be
identified and excluded from analysis with STATA. Patterns of missing values will be
assessed to identify potential bias that may be introduced when deleting subjects. If bias
is found, that variable will not be included in matching.
Overall Analysis Plan
AIM 1: Determine the comparative effectiveness between matched patients from
the Baylor/Ben Taub ED database using VL compared to those using DL in terms of the
first pass success rate as the measurement of “effect.”
Comparative effectiveness will be calculated using a first pass success rate as
measurement of clinical effectiveness. Clinical effectiveness will be determined by
looking at the mean difference in first pass rates between the two technologies (VL or
DL) while controlling for DACs and other confounding factors. Since this data will be
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extracted from a clinical database rather than from a rigorously designed research study,
patients were not randomized into VL or DL groups. In order to reduce selection bias, a
propensity score analysis will be used.
A propensity score analysis is a statistical method developed for estimating
treatment effect using a single score that represents the probability of receiving a
treatment conditional on a set of patient characteristics (covariates) in observational or
quasi-experimental studies (Garrido, et al., 2014; Guo & Fraser, 2015). Propensity
scoring will be used to match subjects who are intubated using DL with a subject who has
a similar profile in the VL group. A single composite score is generated by propensity
scoring and reflects the conditional probability of being intubated with the VL based
upon external characteristics (covariates) that are used for matching. Propensity scores
for this study represent the likelihood that VL would be used for the intubation and range
from 0-1 where 1 equals a subject will be intubated with VL and 0 equals a subject will
not be intubated using the VL.
To generate propensity scores in this study, all potential covariates will be entered
into a logistic regression model without regard to the outcome of being intubated with VL
(Garrido, et al., 2014).
The propensity scores will be checked for balance between the VL and DL groups
and will be evaluated for common support. Common support is the extent that the
distribution of propensity scores of VL and DL groups overlap. Balance will be evaluated
by examining the distribution across VL and DL groups and testing whether the mean
propensity score is equal between both groups. Since the propensity score is based upon
covariates, each observed covariate will then be assessed for balance within quintiles (or
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smaller blocks) (Garrido, et al., 2014). Once balance has been achieved, a single VL
subject will be matched to a single DL subject with the most similar estimated propensity
score using 1:1 nearest neighbor method. Stata programs (teffects, psmatch, and
tebalance) will be used to check for balance of the characteristics between the matched
samples, a p-value of >0.05 will be used as the threshold for assessing balance. These
programs produce box plots that show the degree of balance. For example, in the
proposed database there may be 3000 subjects in the pool; 1000 who have been treated
with VL and 2000 with DL. After matching the subjects, the database is left with 1000
subjects in each group. VL (n=500) and DL (n=500). After checking for equivalence, an
estimation of the treatment effect will be established by comparing the first pass success
rate between the cohorts. Based on the data from these groups, costs will be identified for
VL and DL and placed in the ICER formula.
Specifically, a propensity score estimate will be determined using STATA
software (College Station, TX) for each subject based on the independent variable (DL or
VL) from the pretreatment patient characteristics (Table 2). The pretreatment
characteristics include: age, gender, trauma status, number and type of DACs, GCS,
medications used and if an attempt was made prior to arrival by EMS (Table 2). The
matched patients will be divided into five equal sized groups (strata) according to their
estimated propensity score. Matching will be performed without replacement in order to
prevent adding additional bias or variance (Rosenbaum, 2010). A power analysis with a
priori criteria (alpha = 0.05, beta = 0.8) will be used to determine if the sample size meets
the minimum requirement for those levels. If the sample size is less than the required
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sample size to achieve these minimums, caliper matching without replacement will be
used.
AIM 2: Estimate the incremental cost effectiveness ratio (ICER) using the first
pass rate as the “effect” measurement while controlling for the number and type of DACs
comparing the VL to the DL in the ED from the perspective of the ED administration in
matched patients.
The data analysis for AIM 2 will use the treatment effect calculated from AIM 1
in the calculation for the ICERmean using the sum of the cost variables between the two
devices. The ICER is formulated as:
ICERmean= (Cost VLmean - Cost DLmean)/ (Effect of VLmean – Effect DLmean) and will be
calculated by TreeAge software.
A decision tree cohort model will be used to provide a visual representation of the
scenarios and potential outcomes a subject will encounter when being intubated by either
the video laryngoscope or the direct laryngoscope (Appendix C). Each scenario is
depicted by a pathway from the possible outcomes the subject could encounter. For
example, one pathway would be if the subject was successfully intubated on the first
attempt using the VL and no adverse event occurred. Following the structure of the
model, TreeAge software will be used to determine the cost and effects of the two
competing technologies (VL or DL). Cost for each pathway will be input into the model
of each particular scenario as applicable from Table 2. The cost payoffs specified for
each outcome will be calculated by combining the appropriate costs for each particular
scenario. The probabilities of each intubation attempt will be calculated based on the
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percentage of successful or failed attempts obtained from the databank. The probabilities
of adverse events will be estimated using published data.
A probabilistic sensitivity analysis will be performed using TreeAge software to
simulate the analysis using assumed distributions sampled from the databank for the cost
and effect parameters. A probabilistic sensitivity analysis is used to quantify parameter
uncertainty by using a distribution instead of a single value (Briggs, Sculpher & Claxton,
2006). A Monte Carlo simulation will be used to resample parameter values using 10,000
iterations. The results will be presented using a cost effectiveness scatter plane, where
each iteration is plotted graphically showing the incremental cost and incremental
effectiveness of the intervention evaluated to determine overall confidence in the
conclusions.
Study Limitations
There are several limitations to this study. The data used for this study lacked
randomization where there would ideally be an equal likelihood that the patient could
have been intubated using the VL.
Propensity score matching will be used in order to reduce selection bias.
However, the propensity scoring method is limited in terms of the ability to eliminate
selection bias because it does not correct for unobservable and unmeasured confounding
variables that affect whether one subject was intubated with the VL or the DL.
Eliminating subjects with missing data could introduce measurement bias.
Alternatives to this approach include assessing the data that is missing and add it as a
covariate or performing multiple imputation to handle the missing data (Guo & Fraser,
2015).
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Self-reporting bias will be inherently introduced because the data is collected
from patients’ charts where the provider who performed the intubation is self-reporting.
Ideally, a researcher would record the data in order to prevent this potential source of
measurement bias.
Generalizability will be limited to the facility where the study is performed. Cost
and effect are limited to the sample obtained from the database at the study site. Costs
omitted from this study include reimbursement and hospitalization. Reimbursement will
be excluded because the facility will be reimbursed at the same rate regardless of the
device used. Hospitalization cost will also be excluded because there are too many
confounders that may be introduced that are not relevant to the treatment effect.
Data regarding the cost of AEs will be included. However, there are some
anticipated difficulties that can be attributed to this data reporting. These difficulties
include the inability to define the time when an AE occurred either ideopathically or as a
result of the intubation. Another difficulty anticipated is that AEs are often not noted in
the ED record because they may not be identified immediately. The final anticipated
difficulty is in determining a cost associated with each AE. The only AE reported cost
data has been performed for anesthesia, not emergency medicine. Further investigation of
the cost associated with adverse events is required.
Ideally, an estimate of the cost associated with a second attempt should be
identified in order to account for the potential for VL to save costs by avoiding second
attempts and the potential problems associated with those attempts. A limitation of
dealing with retrospective data is that you can only use the data that was collected and in
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the manner in which it was collected. The time taken for each intubation attempt would
be a great asset to be able to associate a cost with each additional attempt. However, the
most meaningful measure of cost associated with multiple attempts is the potential
increased cost associated with a greater probability for an adverse event to occur. Future
studies should track time for each attempt more precisely.
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Appendix A-1
Cormack and Lehane Grading System

Cormack-Lehane Scale

Note. The Cormack and Lehane grading system for the view of the larynx obtained during direct
laryngoscopy (Cormack & Lehane, 1984)
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Appendix A-2
LEMON Airway Assessment Tool

Note. (Reed, et al., 2005)

Appendix B
Steps in Conducting Propensity Score Matching
Step 1. Choose
variables to include
in the propensity
score
Step 2. Ensure that propensity
score is balanced across
treatment and comparison
groups

Step 3. Ensure that covariates are
balanced across treatment and
comparison groups within blocks
of the propensity score

 List potential confounders
 Evaluate the feasibility of including the confounders
 Calculate the propensity score with logit or probit regression
 Check range of common support
o Extent to which distributions of propensity scores in treatment and comparison groups overlap (Stata, pscore)
 Check balance of propensity score
o Does the propensity score have similar distribution across treatment and comparison group?
o Estimate distribution by splitting sample by quintiles or other strata propensity score
o Test whether mean of propensity score is equal in treatment and comparison groups within each quintile
o If not equal, split one or more quintiles into smaller blocks and compare means
 Ideally, for each unique value of the propensity score, the distribution of X (composite of all covariates) is the same for
the treatment and comparison groups
 Due to practicality, the balance of each observed covariate is examined within blocks of the propensity score (Stata, ttest)
o Improve the balance of the propensity score by focusing on the balance of covariates that are more theoretically
relevant (Stata, error message if not balanced)
 Consider interactions/correlations between covariates
 If not balanced, drop 1-2 covariates that are less important and repeat Step 2
 Re-categorize variables
 Include higher order terms
 If balanced, continue to Step 4

Note. Starks & Garrido (2014)

35

(continued from previous page)

Step 4. Choose a matching or
weighting strategy

 Quality and quantity on continuum
 No universal best strategy
o Nearest neighbor
o Radius matching
o Kernal weighting
o Stratified matching
 Inverse probability of treatment weighting
 Without measuring outcome, evaluate covariate balance in several strategies
 Choose the method that has the best balance and still meets the analytic goal

Step 5. Ensure that covariates are
balanced across treatment and
comparison groups in sample
matched or weighted by
propensity score

 Perform multiple checks
o Standardized differences
 Percentage of bias calculated in matched
o Graphs
 Summary of covariate imbalance that is reported as a summary of mean and median bias pre-and post-matching
(Stata, output from pstest)
 Quantile-quantile plots
 Plots of covariates in treated and comparison groups
 Ratios of variance
 Histogram
o Visualized inspection of standardized difference
Steps 1-5 can be repeated several times as necessary

Step 6. Proceed with analysis
based on sample matched or
weighted by propensity score






Delete observations from individuals not within the range of common support
Choose the treatment effect of interest
Calculate correct standard error for propensity score matched or weighted sample
Guard against misspecification of the propensity score
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Table 1
Seven Steps Involved in Conducting a Cost Effectiveness Analysis (CEA)
Steps of CE Analysis
1. State the problem

Activity
Describe the situation and rationale

Application in Study
Need to compare VL with DL in ED without conducting an
RCT
Pathway patient will encounter when being intubated using VL
or DL using descriptions of the intubation from database

2. Create a conceptual model

Describe the technology and effects on healthcare

3. Define the perspective
4. Identify costs and gather
data to value costs

Define how health outcomes and costs are valued
Identify, measure, and value cost

Perspective is ED Administration
Cost of equipment, training, maintenance, and adverse events

5. Identify and gather data to
validate outcomes

Determine an outcome measurement common to each
technology

Outcome is measured as successful first attempt or failure as
reported in the database

6. Estimate cost effectiveness

Calculate to incremental cost effectiveness ratio (ICER)

ICER= (Cost VL- Cost DL) / (Effect of VL–Effect DL)

7. Perform sensitivity analysis

Determine plausible range that may contain the ICER and
how the parameter estimates vary and affect the CEA

Identify the most influential variables that are most sensitive to
uncertainty

Note. Petitti (2000)
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Table 2
Categories, Variables, Definitions, and Measurement
Category
Independent
Variable
Dependent
Variables

Description/Definition

Measurement

Source

VL or DL

Provider report from chart review

Number of
attempts

Provider report from chart review

Yes or No

Provider report from chart review

Yes or No

Provider report form chart review

Cost of Device (VL)

Video laryngoscope (VL) or Direct laryngoscope
(DL) used for first intubation attempt
Introduction of the device blade (VL or DL) into
the patient’s mouth regardless of whether an
endotracheal tube was inserted or not.
Correct placement of an endotracheal tube into the
trachea on the first attempt.
Intubation requiring more than one attempt,
changing intubator during a single attempt or
changing devices during an attempt will be
considered a failure
The initial cost of purchasing the VL

US $

Cost of Device (DL)

The initial cost of purchasing the DL

US $

Cost of training (VL)

The cost of training the ED providers on the VL
initially (first year)
The cost of training the ED providers on the DL
initially (first year)
The cost of maintaining and repairing VL

US $

The cost of maintaining and repairing VL

US $

Financial report from facility in US
$
Financial report from facility in US
$
Financial report from facility in US
$
Financial report from facility in US
$
Financial report from facility in US
$
Financial report from facility in US
$

Variable
Device Used
First intubation attempt

First attempt success
First attempt failure

Cost of training (DL)
Cost of
maintenance/repair (VL)
Cost of
maintenance/repair (DL)

US $
US $
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Table 2 (continued)
Categories, Variables, Definitions, and Measurement
Category

Variable
DACs

Description/Definition
Obesity/Weight
Large tongue
Mallampati
Short neck
Small mandible
Cervical immobility
Cervical collar in place
Presence of blood or emesis in airway
Facial trauma
Cormack and Lehane
LEMON

Confounding
Variables (Patient
characteristics and
intubator related
characteristics)

Measurement
Kilograms
Yes or No
(Class I, II, III,
IV) (Appendix A2)
Yes or No
Yes or No
Yes or No
Yes or No
Yes or No
Yes or No
Grades I, II, III,
IV) (Appendix
A-1)
Performed
visually by
intubator
(Appendix A)
Chart abstraction

Source
Provider report from chart review

Age

Age in years

Gender
Patient Type
GCS

Male or Female
Trauma or medical patient.
Summation of scores for eye, verbal, and motor
response
Intubation attempted before attempt made in ED

Chart abstraction
Chart abstraction
3-15

Chart abstraction
Chart abstraction
Chart abstraction

Yes or No

Chart abstraction

1. Trauma
2. Arrest
3. Failed to oxygenate
4. Failed to ventilate

Chart abstraction

Chart abstraction

Intubation attempt
before arrival to ED by
EMS
Indication for
Intubation

Chart abstraction

39

Table 2 (continued)
Categories, Variables, Definitions, and Measurement
Category

Intubator related
factor

Variable

Description/Definition

Measurement

Source

1. Medications used to
perform intubation

1. Paralytic and sedation
2. Sedation only
3. None

Chart abstraction

2. Provider experience

1. Year in residency training (Program year
[PGY])
2. Attending (MD or DO)
3. Nurse Practitioner (NP) or Physician Assistant
(PA)
4. Medical Student
Resident from service other than ED

Paralytics:
Succinylcholine,
Vecuronium,
Rocuronium
Sedation:
Etomidate,
Versed, Ketamine
1. PGY 1-4
2. Attending
Physician
3. NP or PA
4. Medical
Student
5. Off-service
Resident

Chart abstraction

Note. DACs, PGY, NP, PA, GCS, EMS, VL, DL
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Table 3
Most Common Reported Adverse Events Associated with Emergency Intubation
Description/Definition

Measurement

Source

Oxygen
Desaturation
Aspiration

SPO2 < 80% during intubation attempt(s)

Yes or No

Chart abstraction

Presence of vomit at the glottic inlet visualized during intubation in a previously clear airway

Yes or No

Chart abstraction

Failed Intubation

More than two attempts without successful placement of the ET tube in the trachea

> 2 attempts

Chart abstraction

Cardiac Arrest

Asystole, bradycardia, or dysrhythmia w/non-measurable BP & CPR during or after intubation
(5 min)

Yes or No

Chart Abstraction

Pneumothorax

Yes or No

Chart Abstraction

Dental trauma

Identified on a post intubation chest radiograph in the absence of chest trauma to the affected
side
Injury to teeth (Fracture or avulsion)

Yes or No

Chart Abstraction

Bleeding

Blood in mouth or airway

Yes or No

Chart Abstraction

Hypotension

Decrease in systolic blood pressure to <90 mmHg, unexplained by underlying pathophysiology

Yes or No

Chart Abstraction

Yes or No

Chart Abstraction

Variable

Esophageal
ET tube placed in esophagus
Intubation
Note. (Brown et al., 2015; Sakles et al., 2013).
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Appendix C
Decision Tree Cohort Model

Note. Decision tree cohort model illustrating the potential pathways the subject
could encounter when being intubated by the video laryngoscope or direct
laryngoscope.

43
Cover Letter to Editor for Manuscript Submission

July 17, 2017
K. Sue Hoyt, PhD, RN, FNP-BC, ENP-C, CEN, FAEN, FAANP, FAAN
Emergency Nurse Practitioner
St. Mary Medical Center
1050 Linden Ave
Long Beach, CA 90813
Dear Dr. Hoyt,
I am writing you regarding the submission of our manuscript to Advanced Journal of
Emergency Nursing. The manuscript is entitled, “Comparing the Effectiveness of the
Video Laryngoscope with the Direct Laryngoscope in the Emergency Department: A
Meta-Analysis of the Published Literature.” This manuscript examines the first pass
success rate of video laryngoscopy compared with direct laryngoscopy in adult patients
intubated in the emergency department.
Given that there is major debate regarding whether VL should replace the DL as the
standard intubation practice, we believe that the findings presented in our paper will
appeal to the Advanced Practice Providers who subscribe to AJEN. Our findings will
allow your readers to determine the current state of evidence available when comparing
these devices in the emergency department.
This manuscript has not been previously published nor has it been submitted to other
journals.
Thank you kindly for your consideration.
Sincerely,

D. Sean DeGarmo, PhD, RN, ENP-BC, FNP-BC, CNSA-BC, LP
University of Texas Health Science Center at Houston
School of Nursing
6901 Bertner
Houston, Texas 77030
Daniel.s.degarmo@uth.tmc.edu

44
MANUSCRIPT

Comparing the Effectiveness of the Video Laryngoscope with the Direct
Laryngoscope in the Emergency Department: A Meta-Analysis
of the Published Literature

45
Manuscript Abstract
Purpose: Rapid intubation is essential for the critically ill patient in the emergency
department to ensure adequate oxygenation. Regardless of presenting illness or injury,
the first pass success rate (FPSR) can impact patient morbidity and mortality. The study
aim was to evaluate the FPSR of direct laryngoscopy (DL) compared with video
laryngoscopy (VL) in adult patients intubated in the emergency department. Methods:
Ovid Medline, Cochrane Library database, Embase, and Google Scholar were searched
for peer-reviewed articles on studies of human subjects reporting a comparison of FPSR
between VL and DL in adult patients who were orotracheally intubated in the emergency
department. A meta-analysis was carried out using odds ratio (OR) as the summary effect
measure for FPSR. A pooled effect size with the 95% Confidence Interval (CI) was
calculated using a random effect model with inverse weighted method. Results: 8,428
intubations (5,840 DL and 2,588 VL) from nine studies (five observational and four
randomized controlled trials) were included in the sample. The pooled OR for FPSR
across all studies was 1.89 [95% CI = 1.17, 3.07; p < 0.01], favoring VL when compared
with DL. The results were limited by potential bias (selection and performance) and high
levels of heterogeneity [I2 = 88%; 95% CI: 79%, 93%; Q = 64.61; p < 0.01].
Conclusions: Threats to validity made it difficult to conclude with certainty that one
device is better than the other for achieving a successful intubation on the first attempt in
the emergency department.
Keywords: emergency, intubation, video laryngoscopy, meta-analysis
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Background
Establishing and maintaining a patent airway in a critical care situation is
paramount to patient survival. Proactive airway assessment and protection are especially
important in a critical care area such as an emergency department (ED). Emergency
intubation is associated with a high rate of complications, including intubation failure,
multiple attempts, prolonged periods without ventilation and esophageal intubation.
Errors occur more frequently with providers who infrequently perform intubation (Nable,
Lawner, & Stephens, 2012; Wang & Yealy, 2006; Wayne & McDonnell, 2010). Failure
to secure an airway has been associated with an increase in morbidity and mortality in
operative and emergency settings (Malik, Maharaj, Harte, & Laffey, 2008; Niforopoulou,
Pantazopoulos, Demestiha, Koudouna, & Xanthos, 2010). Difficulty in laryngeal
visualization is one of the leading causes of intubation failure (Malik et al., 2008;
Niforopoulou et al., 2010). The first intubation attempt is critical as multiple attempts
increase the likelihood of adverse events (AEs): airway trauma, aspiration, dysrhythmias,
hypoxemia, anoxia, brain injury or death (Jaeger, Ruschulte, Osthaus, Scheinichen, &
Heine, 2000; Nable et al., 2012; Sakles, Chiu, Mosier, Walker, & Stolz, 2013; Wang &
Yealy, 2006).
While there have been advances identifying patients who may be difficult to
intubate, difficult intubations have been reported to occur in 4% to 26% of all intubations
performed in the ED (Sakles, Laurin, Rantapaa, & Panacek, 1998; Wong & Ng, 2008).
Difficult airway characteristics have been associated with increased intubation difficulty
and can be used to identify patients who are at risk for intubation failure (Sakles,
Patanwala, Mosier, & Dicken, 2014). The current standard for intubation technology is
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direct laryngoscopy (DL), a technology that has been in use since the 1940’s (Jephcott,
1984). A more recent technology, video laryngoscopy (VL), available since 2001, was
designed for patients with known or predicted difficult airway characteristics (Cooper,
Pacey, Bishop, & McCluskey, 2005; Xue et al., 2007).
There has been much debate regarding whether VL should replace the DL as the
standard intubation practice (Rothfield & Russo, 2012). In the operating room, there is
limited substantiation for this change; however, intubating in the ED presents a
challenging situation because of the high risk, low-frequency nature of the procedure and
the variability of intubation experience among providers when compared with operating
room providers who perform this procedure routinely (Cook & MacDougall-Davis,
2012). Unlike the operating room, there are situational stressors present in the ED that
may make intubation more challenging, including high patient acuity, cervical restriction,
noise, inadequate staffing, poor patient oxygen reserves, as well as the necessity to secure
an airway in the patient who may or may not have a known difficult airway. The situation
is further compounded by physiologic time constraints posed by a deteriorating patient;
much greater risk for vomiting and aspiration because patients have not fasted; and, the
frequent presence of blood and secretions not seen in the operating room (Brown, Bair,
Pallin, Laurin, & Walls, 2010; Griesdale, Liu, McKinney, & Choi, 2012; Shah et al.,
2011).
Systematic reviews and meta-analyses comparing VDL devices have reported an
increase in first pass success with the use of VL (De Jong et al., 2014; Griesdale et al.,
2012); however, these studies were limited to adults intubated in the operating room or
intensive care unit (ICU) and did not examine subjects who were emergently intubated in
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the ED. In 2012, Griesdale et al. published a meta-analysis comparing the Glidescope
(VL) to the DL using studies with a randomized controlled trial (RCT) and quasirandomized experimental designs. The authors reported no significant difference in the
first-pass success rate (FPSR) when comparing VL with DL. De Jong et al. (2014)
published a meta-analysis comparing FPSR achieved using VL, compared with using the
DL, in the ICU. The authors reported an odds ratio (OR) favoring the VL in FPSR
compared with the DL (OR=2.07, 95% CI 1.35, 3.16; p<0.001). The meta-analysis
described in this current manuscript focused on adults who require emergent intubation in
the ED setting because the ED represents a unique clinical area, with specific challenges
related to high patient risk and low-frequency intubation.
Methods
Study Design
The purpose of this study was to determine the FPSR of VL compared with DL
in adult patients intubated in the ED. This study was conducted by performing a
systematic review and meta-analysis of the published literature.
Search Strategy
The main search was constructed in Ovid Medline on December 15, 2016. Using
terms harvested from relevant published literature (see Box 1), the terms were then
mapped to subject headings, title, abstract, and keyword searches. This search strategy
was then translated into the Cochrane Library, Embase, and Google Scholar databases.
The Google Scholar search was limited to the first 100 articles retrieved and sorted by
relevancy. Following the recommendations of the librarian, a pre-set limit of the first 100
articles was established because of the algorithm the Google Scholar search engine uses
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is constantly changing and can result in thousands of entries not related to the subject
matter. The first 100 articles are typically the best matches and most relevant citations.
The CINAHL database was not included in the search because the potential limitations
when searching for published literature. No date limits were given as the subject matter is
date limiting. A reference list search was performed on February 28, 2017, to locate
additional studies; this search resulted in four additional studies to be evaluated for
inclusion.
Selection Criteria
The researcher and a librarian independently screened abstracts and qualifying
articles recorded with Rayyan systematic review software (Ouzzani, Hammady,
Fedorowicz, & Elmagarmid, 2016). The Rayyan systematic review tool was used to
upload database searches to filter, label, identify duplicate articles. The blinding function
in Rayyan was enabled to reduce selection bias. Articles were included if they reported a
comparison of FPSR between VL and DL in adult patients (18 years old or older) who
were intubated orotracheally in the ED and were described as RCTs or observational
studies. Manikin studies, simulations, case reports, reviews, and articles that reported
intubations outside of the ED setting (e.g., operating room, ICU, pre-hospital), pilot
studies, and studies that contained pediatric patients were excluded.
To avoid duplication, six studies (Cho, Cho, Chung, & Investigators, 2015; Choi
et al., 2010; Kim et al., 2012; Mosier, Stolz, Chiu, & Sakles, 2012; Sakles, Mosier,
Patanwala, & Dicken, 2014; Sakles, Mosier, Chiu, & Keim, 2012) were excluded that
reported using the same registry/database collected during the same date range. Lee et al.
(2016) reported data collection during two separate time periods, reported as seasons.
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Results from season I were excluded because Choi et al. (2015) reported results from the
same data base during the same period. Data reported from season II were included in
this review because the period was independent of other studies reporting results from the
same registry/database (Lee, Kang, & Choi, 2016).
Two studies (Sakles, Mosier, Chiu, Cosentino, & Kalin, 2012; Sakles, Mosier,
Patanwala, Arcaris & Dicken, 2016) were excluded because the C-MAC without the
video component was considered DL. Intubators used the C-MAC on the first attempt
with the video camera turned off (considered DL) and then turned the video camera on if
they were having difficulty intubating (considered VL) during that same attempt. These
studies were excluded because the definition of an effort using VL versus DL was unclear
when changing from the VL to DL method. The threshold may be lowered for changing
from VL to DL due to the ease of switching from one method to the other.
Quality Assessment
Cochrane Collaboration tools for randomized controlled trials (RCT) and cohort
studies were used to assess selection, performance, detection, attrition, reporting, and
other sources of bias (see Tables 3A & 3B). Selection bias was assessed by evaluating the
adequacy of random sequence generation and allocation concealment. Performance and
detection biases were evaluated by the adequacy of blinding. Attrition bias was evaluated
by assessing the number and percentage of participants for whom outcomes were not
reported. Reporting bias was evaluated by the adequacy of reported findings. Other
sources of bias included such conditions as a population markedly deviant from the
majority of the other studies included in the review. The risk of bias tool for
observational studies additionally addressed potential confounding variables that may
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impact the observed effect, including eligibility criteria, temporal differences in
intervention administration, and intubation outcome(s) reported by the intubator (see
Table 3A).
Data Extraction
Data were independently abstracted by the researcher and an assistant into Excel
spreadsheets. Data abstracted included publication author(s), publication date, purpose of
study, study design, study location, number of EDs included in the study, sample size,
date range of data collection, exclusion criteria, relevant outcomes, outcome definitions
and measurement method(s), VL device type, experience and type of intubator,
proportion of trauma/medical patients included in the population studied, number of
subjects with difficult airway characteristics and method used to assess the
characteristics, adverse events reported, VL and DL training provided to intubators.
Analysis
Included Studies
The initial literature search resulted in 366 citations, and the manual reference list
check found four additional citations (Figure 1). After removing 71 duplicates and 240
articles that did not meet eligibility criteria based on a review of the title and abstract, 58
articles were retrieved; 41 of these were excluded based on eligibility criteria. Nine
articles were included in the meta-analysis: four RCTs and five observational studies
(Figure 1).
Study Characteristics
Population. The mean age (50.52 years) and age range (19.5 and >100 years old)
of subjects were consistent across studies, although subjects included in the Goksu, Kilic,
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Yildiz, Unal, & Kartal, (2016) study were younger (VL 35+/-15.5 years and DL 39 +/-19
years). The gender of subjects also was consistent across studies; approximately 51% of
subjects were male. All study reports included data from participants who were exposed
to trauma. Two studies (Park et al., 2015; Sulser et al., 2016) excluded trauma patients
who were immobilized in cervical collars. Park et al. (2015) reported data obtained
exclusively from participants intubated during cardiac arrest, regardless of exposure to
trauma. While Choi et al. (2015), Sulser et al. (2016), and Yeatts et al. (2009) excluded
data from participants intubated during cardiac arrest.
Intervention. A total of 8,428 intubations (2,588 VL and 5,840 DL) were
included in the analysis of the nine studies. Observational studies accounted for nearly
87% of the total intubation attempts. There were two types of VL devices found in the
studies that were utilized which included the GlideScope (GVL) and the C-MAC. The
GVL was used in all the observational studies, while the CMAC was utilized in all but
one (Yeatts et al., 2013) of the RCTs.
Most studies defined an intubation attempt as the introduction of the laryngoscope
into the patient’s mouth, and the attempt was considered completed when the
endotracheal tube and laryngoscope were removed. Goksu et al. (2016), Platts-Mills et al.
(2009), and Sakles et al., (2017) used a more precise definition, explicitly stating that the
introduction of the laryngoscope into the patient's mouth was considered an attempt,
regardless of any effort made to insert an endotracheal tube. Park et al., (2015) did not
explicitly state their definition of an intubation attempt; however, they defined the time to
complete an intubation as "the time from the advancement of the blade into the patient’
mouth to the delivery of the first successful ventilation using the bag.” Because the first
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part of the Park et al. definition mirrors the explicit definition in an effort by other
studies, there is confidence in the assumption that the Park et al. definition of an effort is
congruent with other studies included in this analysis.
There were variations in classification of data that reported on training,
experience, and identification of a potential or difficult airway. Provider training and
expertise were extremely diverse; some providers had no experience at all using the VL
while others had extensive experience, including those anesthesiologists with a minimum
of seven years of experience. One study (Platts-Mills et al., 2009) noted that for some
intubators utilized VL on a real patient for the first time as part of the study protocol. In
most of the studies, the number of intubations each provider had experienced was
difficult to determine, and there was much variation in experience. Rather than reporting
the experience by each provider with a minimum number of intubations they have
performed with each device, the experience was reported by the year of medical
education status. Even then, there was no consistency in how the studies stratified
intubator experience level. It appeared that most intubators had some training in using the
VL across studies. However, there was not a standard minimum. Training ranged from
two 30-minute orientation sessions provided by the manufacturer (Platts-Mills et al.,
2009) to highly skilled staff anesthesiologists with at least seven years of experience
(Sulser et al., 2016).
There was no consistency in the measurement or instrument used to identify a
difficult airway. The majority of the studies, (except Driver et al., 2016; Park et al., 2015)
utilized one or more components of the LEMON pneumonic, according to the assessment
method for difficult glottis exposure with laryngoscopy (look externally, evaluate mouth
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opening, thyromental distance, hyothyroidal distance, morbid obesity, airway obstruction,
and neck mobility]. Driver et al. (2016) did not use a formalized measure but relied on
the provider’s judgment to determine if the intubation was difficult or not. There was no
report of either a measurement or instrument by Park et al. (2015).
Setting. All the studies were conducted in Academic Emergency Departments. Of
the nine studies, four were carried out in the United States, three in Korea, one in Turkey
and one in Switzerland. The studies performed in Korea reported data from two or more
EDs (Choi et al., 2015 reported data from four EDs); the other EDs abstracted data from
single sites.
Adverse events. There were only three types of adverse events reported:
esophageal intubations, aspiration pneumonia, and hypoxemia. Two studies reported
esophageal intubations (Goksu et al. 2016; Park et al. 2015). There were no cases of
esophageal intubations using the VL (0/75; 0/49). Both studies did report esophageal
intubation using the DL (7/75; 6/34). Two studies reported higher incidents of hypoxemia
using VL than DL. Driver et al. 2016 reported 26/103 intubations using VL and 26/95
intubations using DL. Yeatts et al., 2013 had 27/54 using VL and 15/63 using DL. Only
one study (Driver et al., 2016) reported aspiration pneumonia, and there were fewer cases
of reported using VL than DL (VL 7/96; DL 11/90). Sulser et al., reported no adverse
events by using either device. Adverse events were not listed in two of the studies (Choi
et al., 2015; Lee et al., 2016) There were two studies that reported cricothyrotomies in
both the VL and DL groups. Platts-Mills et al., (2009) reported one of the patients who
was assigned to the DL group had a cricothyrotomy performed. In Sakles et al., (2017),
there were four patients (4/950) who had cricothyrotomies performed that the initial
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effort was VL, and only one subject had a cricothyrotomy who had an initial attempt was
using DL it could not be determined if this was an adverse event from the first effort or if
there were multiple attempts made.
Analysis of the Outcomes
First-Pass Success Rate
These nine studies reported discrete FPSR based on independent samples of
patients in the ED who were emergently orotracheally intubated. The FPS of DL ranged
from 55.88% to 100%. The FPS for VL was 62.67% to 98.6%. The mean DL FPS was
77.40 % and 86.2% for the VL (see Table 2). None of the RCTs reported a significant
difference in the FPS between the VL and DL. Two of the observational studies reported
a significant difference: VL 419/442 (94.8%); DL 365/479 (76.2%), p <0.001 (Lee et al.,
2016); VL 45/49 (91.8%); DL 19/34 (55.9%), p <0.001 (Park et al., 2015).
The pooled Odds Ratio (OR) for first pass success across all studies was 1.89
[95% CI 1.17-3.07, p< 0.01] (see Figure 2), indicating a higher first pass attempt rate for
VL than DL (see Table 2). There was significant heterogeneity observed in the metaanalysis, I2 = 88% [79%; 93%] with Q = 64.61 and p-value < 0.01.
In the subgroup analysis by study type (Figure 3), the observational studies
exhibited a statistically significant effect of VL against DL with Odds Ratio 2.49 [95%
CI 1.32-4.71, p< 0.01]. In the subgroup analysis by VL Device Type (see Figure 4), the
GlideScope (GVL) OR was 2.08 [95% CI 1.17-3.73, p<0.01], indicating better odds of
achieving a successful intubation on the first pass with the GVL compared to the DL.
There were no statistically significant results from the subgroup analysis by study
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location (Figure 5), either study conducted in the USA or those not carried out in the
USA.
Computation of Effect Sizes
A meta-analysis was performed using the Odds Ratio (OR) as the summary
measure for FPSR. A pooled effect size with the 95% Confidence Interval (CI) was
calculated using the Random Effect Model with the inverse variance weighted method (R
Core Team, 2017). A sensitivity analysis was also carried out. A sensitivity analysis is
employed to determine how dissimilar values of an independent variable effect a specific
dependent variable under a particular set of assumptions. A meta-analysis was performed
with a sensitivity analysis to evaluate the robustness of the meta-analysis (Sutton et al.,
2000). The leave-one-out method was conducted by removing one study at a time and
measuring the pooled estimate (Figure 8). Analyses were conducted with the "meta"
package in the R environment (R Core Team, 2017; Schwarzer, 2007).
Analysis of the Quality of the Studies
Threats to Validity
Heterogeneity is a known threat to the validity of meta-analyses. Heterogeneity
among studies was assessed using the chi-square (Χ²) and quantified with the I2 index to
determine whether observed differences were real or by chance (Higgins, Thompson,
Deeks, & Altman, 2003). A low p-value (or a large Χ² relative to its degree of freedom)
provides evidence of heterogeneity of intervention effects (variation in effect estimates
beyond chance). The I2 index is interpreted as: 0% to 40%, low heterogeneity; 30% to
60%, moderate heterogeneity; 50% to 90%, substantial heterogeneity and 75% to 100%,
considerable heterogeneity (Higgins & Greene, 2011). For the present study, a I2 index >
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60% indicated substantial heterogeneity and was assessed using subgroup analysis.
Subgroup analyses for study design, location, VL device type, training, cardiac arrest,
and trauma were assessed for potential sources of heterogeneity.
Another threat to the validity of the summary effects is publication bias (studies
with statistically significant or clinically favorable results are more likely to be published
than studies with non-significant or unfavorable results). Other biases subsumed under
publication bias are time lag bias (studies with unfavorable findings take longer to be
published), language bias (non-English language articles are more likely to be rewritten
in English if they report significant results), and selective outcome reporting (where nonsignificant study outcomes are entirely excluded from publication). Such biases lead to
meta-analyses which synthesize an incomplete set of the evidence and produce summary
results potentially biased towards favorable treatment effects (Sutton, Abrams, Jones,
Sheldon & Song, 2000).
The existence of publication bias was evaluated by funnel plot symmetry.
A funnel plot is a scatterplot of treatment effect against a measure of study precision
(Light & Pillemer, 1984). The points of the scatterplot will form in the shape of a funnel
centrally around the total overall estimated effect that is symmetrical in shape in the
absence of reporting bias (Light & Pillemer, 1984).
Egger’s test was used to confirm the presence and magnitude of publication bias
(Egger, Smith, Schneider, & Minder, 1997). The impact of missing data was evaluated by
the trim-and-fill method (Duval & Tweedie, 2000) that also provides an estimated
intervention effect ‘adjusted’ for publication bias (based on the filled studies). Grubbs’
(1969) test was used for outlier detection in determining the distribution of the effect size
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(odds ratio) values. An outlier was determined if the confidence intervals did not overlap.
The impact of missing data was assessed by trim-and-fill method (Borenstein et al.,
2009).
Risk of Bias in Included Studies
Primary sources of bias included method of device selection, data collection
methods, and protocol deviations. Most of the reports from observational studies stated
that device selection was made by the intubator rather than following protocol. Data
collection by intubator self-report was found across both types of study design, increasing
the risk of detection bias. Protocol deviation was present in three of the RCT study
reports (Driver et al., 2016; Goksu et al., 2016; Yeatts et al., 2013). Yeatts et al. (2013)
removed 210 patients from randomization because three attending anesthesiologists did
not follow and excluded the data from analysis. In Driver et al., (2016), five subjects
assigned to the DL were intubated with VL and 16 patients assigned to VL were
intubated using the DL, authors excluded data from those subjects during analysis;
however, data from those 16 subjects were included in their report. Goksu et al. (2016)
reported three subjects assigned to DL were exposed to VL and six patients assigned to
VL were exposed to DL. Authors did not provide a clear report of how the data from
these subjects were handled during the analysis. Table 3A lists detailed information about
the risk of bias in studies included in this meta-analysis.
Risk of Publication Bias
Although several studies are out of the funnel shape, the funnel plot is
symmetrical for this meta-analysis, indicating no significant evidence of publication bias
(see Figure 6). Further indication demonstrating there was no significant publication bias
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was confirmed by the Egger’s test (p= 0.9611) and Begg’s (1994) test (p = 0.6767).
Using trim-and-fill method (Figure 7), estimated values of the possible missing data were
input. Only one replacement was required on the right side of the funnel plot in the trimand-fill method. After the replacement, the pooled OR was 1.95 [95% CI 1.21-3.16, p =
0.0061], which did not alter the pooled estimate of the main data OR of 1.89 [95% CI
1.16-3.07, p= 0.0098]. Again, these results indicate there is no significant effect of the
missing data for this meta-analysis.
Outliers
The test showed that there are two outliers in the studies, Lee et al., 2016 OR:
5.69 [95% CI 3.56-9.10]and Park et al., 2015 OR: 8.88 [95% CI 2.61-30.28]. Both
studies are observational studies and have very high Odds Ratios(OR), which may affect
the pooled Odds Ratio.
Subgroup Analysis
In the subgroup analysis, the results showed that the sources of heterogeneity
could be attributable to the Observational Studies and GVL device Type. To see how
much heterogeneity is caused by these two studies (Lee et al., 2016 and Park et al., 2015),
the studies were removed, and the meta-analysis was performed. With the presence of
these studies the heterogeneity was I2 = 87.6% [95% CI 78.6%-92.8%], and with the
absence of these studies the heterogeneity was I2 = 82.1% [95% CI 64.3%-91.1%].
Robustness of the Meta-Analysis
From the results of heterogeneity from the subgroup analysis, outliers, sensitivity
analysis, and cumulative analysis it is observed that two studies Lee et al., (2016) OR:
5.69 [95% CI 3.56-9.10] and Park et al., (2015) OR: 8.88 [95% CI 2.61-30.28] are
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primarily causing an apparent deviation from the results. Both of studies are
observational and use the GVL device. These studies produce a slight deviation in the
forest plot of sensitivity analysis and cumulative meta-analysis (see Figure 8).
Discussion
This review included nine studies comparing the impact of VL with DL on FPSR
in adults who required emergent intubation in the Emergency Department. The pooled
OR for FPSR across studies was 1.89 [95% CI 1.17, 3.07; p< 0.01] favoring VL when
compared with DL; this OR is considered a small summary effect (Chen, Cohen & Chen,
2009) and there was significant heterogeneity associated with it.
The meta-analysis is the statistical procedure for combining data from multiple
studies. When the effect size is consistent with one study to the next, meta-analysis can
be used to determine this common effect. However, when the effect varies from one
study to the next, a meta-analysis may be utilized to identify the reasons for the variation.
In this meta-analysis, there was significant variation among the studies.
Subgroup analyses were performed for study design, patient characteristics and
intubator-related factors to identify the sources of heterogeneity (Borenstein et al., 2009).
There has been debate as to whether observational studies and RCTs should be combined
when performing a meta-analysis because of variability in study design and risk of bias.
Although there is support for the inclusion of both observational studies and RCTs, it is
recommended that they be analyzed separately (Borenstein et al., 2009). A meta-analysis
concluded there was no significant difference in effect estimate between observational
studies and RCTs, regardless of observational study design and heterogeneity
(Anglemyer, Horvath, & Bero, 2014). Therefore, the two study design types were
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combined as a likely source of heterogeneity. Subgroup analyses of observational studies
and RCTs showed that the RCTs were homogeneous, indicating that the findings among
the RCTs were similar and consistent and the observational studies were a source of
variance, as shown in Figure 2. All but one of the observational studies reported that the
provider had the ability to choose which device to use on which patient. This practice
risks introducing selection and performance bias. Even the RCTs, which used “intention
to treat” analysis, subject assignment to the intervention was not consistently randomized.
A critical feature of RCTs is that randomization and blinding limit bias by
controlling for known and unknown confounders (Borenstein, 2009). Performing RCTs
in the ED is a challenge because one cannot blind the intubator, and the intubator knows
that patient characteristics (maxillo-facial trauma, cervical spine immobilization (Sulser
et al., 2016; Driver et al., 2016), blood or vomitus in the airway, airway edema, small
mandible, short neck, large tongue, restricted mouth opening and obesity (Sakles et al.,
2017) may make the intubation difficult. Such characteristics may not have been
anticipated until immediately before or during the initial intubation attempt, forcing a
reassessment of the airway and device choice.
Clinical heterogeneity, variability in participants, interventions, and outcomes
(Higgins & Green, 2011), likely influence the true intervention effect from study to study.
The two studies (Park et al., 2015; Sulser et al., 2016) with the most extreme ORs (0.33
and 8.88) differed completely in intubator experience and subjects they included or
excluded. Park et al. (2015) reported data obtained exclusively from participants
intubated during a cardiac arrest while Sulser et al. (2016) excluded data from
participants intubated during a cardiac arrest. Subgroup analyses on trauma, full arrest,
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intubator experience, and training could not be performed because of the inability to
parse them out to observe if they were confounders. Other sources of variance are likely
due to the inability to detect a confounder that was controlled in randomized studies,
which is the major bias in observational studies compared with RCTs (Valentine &
Thompson, 2013). The GlideScope (GVL) device was a source of heterogeneity (I2 =
92%) (see Figure 4).
Statistical heterogeneity is evidenced by greater variation in effect size between
studies than one would expect due to random error (Higgins & Green, 2011). However,
subgroup analysis excluding the two studies with outlier effect sizes (Lee et al., 2016;
Park et al., 2015) did not improve the heterogeneity estimates materially; therefore, these
studies were not a significant source of heterogeneity (see Figure 6).
In an effort to identify other sources of heterogeneity, a subgroup analysis was
performed with studies where data were collected before 2011 compared with studies in
which data were collected in 2011 and later. The Sakles et al. (2017) article was excluded
because they reported data that included both pre-and-post 2011. The rationale for this
was exposure to, and experience with, a VL device limited to before 2011 as
demonstrated by the number of VL attempts outnumbering DL attempts by more than 4
to 1 (VL=906; DL=403) in studies reporting data before 2011. VL and DL attempts were
almost equal from 2011 to 2015 (VL=732; DL=767;). This also was a source of
heterogeneity I2=79% (p<0.0001).
This may be the first meta-analysis to compare the devices for emergent
orotracheal adult intubation in the ED. There have been systematic reviews and metaanalyses comparing these devices in other settings (De Jong et al., 2014; Griesdale et al.,
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2012; Lewis, Butler, Parker, Cook, & Smith, 2016). Those meta-analyses had similar
challenges with heterogeneity. In 2012, Griesdale et al. published a meta-analysis
comparing the GlideScope to the DL from RCTs and quasi-randomized trials not limited
to the ED. When analyzing the FPSR, they reported significant heterogeneity (I2 =88.9%)
and found intubator experience level and potential airway difficulty were sources of
heterogeneity. Unfortunately, the data could not be extracted to perform a subgroup
analysis for either of these moderators. In 2014, DeJong et al. published a meta-analysis
comparing the VL to the DL in the ICU and found similar findings favoring VL
(OR=2.07; 95% CI 1.35, 3.16; p<0.001) similar to the present study favoring the VL in
FPSR compared with the DL. They also combined RCTs with observational studies and
found significant heterogeneity (I2 =68%), which they attributed to a trauma study. Lewis
et al. (2016) published a meta-analysis in the Cochrane Library comparing the VL to the
DL for adult patients. Their study differed from the present one in that they only
reviewed RCTs and included participants scheduled for surgery and patients requiring
tracheal intubation in the ICU as well as the ED. Lewis and colleagues attributed an OR
of 1.27 (95% CI 0.77, 2.09) favoring the VL and significant heterogeneity (I2 =79%),
attributed to performance bias (blinding of participants and personnel).
Conclusion
Based on results of this meta-analysis, it cannot be concluded with certainty that
one device is better than the other for achieving successful intubation on the first attempt
in the ED. For example, significant heterogeneity prevented appropriately combining
studies. However, even with the risk of bias found in the RCT’s, there was still
acceptable heterogeneity. Moreover, the difference between the studies was not due to
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happenstance. Uncertainty also resulted from (a) variability in the observational studies
(confounder was controlled in randomized studies); (b) selection and performance bias in
the ED setting; and (c) clinicians’ utilization of whichever device they are most
comfortable with to achieve a successful intubation, as demonstrated by protocol
violations that occurred in the RCTs. There also needs to be standardized reporting for
these outcomes. Therefore, these issues need to be addressed in future study protocols.
Box 1
Electronic Database Search Strategy
Ovid Medline Database
1. intubation/ or intubation, intratracheal/
2. intubation*.ti,ab,kw.
3. 1 or 2
4. laryngoscopy/ or laryngoscopes/
5. (glidescope or c-mac or v-mac or mcgrath or king vision or pentax or copilot or
vividtrac or miller or macintosh or laryngoscop*).ti,ab,kw.
6. 4 or 5
7. treatment outcome/ or (first pass or success* or overall success or attempt* or fail*
or event).ti,ab,kw.
8. emergency service, hospital/ or trauma centers/
9. (ER or emergency room* or emergency department* or trauma center*).ti,ab,k
10. 8 or 9
11. adult/ or adult*.ti,ab,kw.
12. 3 and 6 and 7 and 10 and 11
Embase Database
1. 'adult'/exp OR adult*
2. AND
3. 'emergency health service'/exp OR 'emergency ward'/exp/mj OR ('er'/exp OR er
OR 'emergency'/exp OR emergency AND room* OR 'emergency'/exp OR
emergency AND department* OR 'trauma'/exp OR trauma AND center* OR
'emergency'/exp OR emergency AND ('health'/exp OR health))
4. AND
5. 'treatment outcome'/exp OR (outcome* OR first AND pass OR success* OR
overall AND ('success'/exp OR success)) OR attempt* OR fail* OR event
6. AND
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7. 'intubation'/exp OR intubat*
8. AND
9. 'laryngoscope'/exp OR 'direct laryngoscopy'/exp OR 'videolaryngoscope'/exp OR
('dl' OR 'vl' OR 'glidescope'/exp OR glidescope OR 'c mac'/exp OR 'c mac' OR 'v
mac' OR 'mcgrath'/exp OR mcgrath OR king AND ('vision'/exp OR vision)) OR
pentax OR copilot OR vividtrac OR miller OR macintosh OR laryngoscop*
10. 12.21.16
11. Embase Session Results
12. 'emergency ward'/exp/mj OR (er:ab,ti OR emergency:ab,ti AND room*:ab,ti OR
emergency:ab,ti AND department*:ab,ti OR trauma:ab,ti AND center*:ab,ti) OR
'emergency health service'/exp
13. AND
14. 'treatment outcome'/exp/mj OR (outcome*:ab,ti OR first:ab,ti AND pass:ab,ti OR
success*:ab,ti OR overall:ab,ti AND success:ab,ti) OR attempt*:ab,ti OR fail*:ab,ti
OR event:ab,ti
15. AND
16. 'intubation'/exp/mj OR intubat*:ab,ti
17. AND
18. 'laryngoscopy'/exp/mj OR ('dl':ab,ti OR 'vl':ab,ti OR glidescope:ab,ti OR 'c
mac':ab,ti OR 'v mac':ab,ti OR mcgrath:ab,ti OR king:ab,ti AND vision:ab,ti) OR
pentax:ab,ti OR copilot:ab,ti OR vividtrac:ab,ti OR miller:ab,ti OR macintosh:ab,ti
OR laryngoscop*:ab,ti OR 'laryngoscope'/exp OR 'direct laryngoscopy'/exp OR
'videolaryngoscope'/exp
19. AND
20. 'adult'/exp/mj OR adult*:ab,ti
Cochrane Library Database
1. (intubat*)
2. AND
3. ("dl" or "vl" or glidescope or c-mac or v-mac or mcgrath or king vision or pentax
or copilot or vividtrac or miller or macintosh or laryngoscop*)
4. AND
5. (outcome* or first pass or success* or overall success or attempt* or fail* or event)
6. AND
7. (ER or emergency room* or emergency department* or trauma center*)
8. AND
9. (adult*)
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Google Scholar
1. intubation
2. AND
3. laryngoscop*
4. AND
5. (outcome* or first pass or success* or overall success or attempt* or fail* or event)
6. AND
7. adult*
8. ("dl" or "vl" or glidescope or c-mac or v-mac or mcgrath or king vision or pentax
or copilot or vividtrac or miller or macintosh or laryngoscop*)
9. AND
10. (outcome* or first pass or success* or overall success or attempt* or fail* or event)
11. AND
12. (ER or emergency room* or emergency department* or trauma center*)
13. AND
14. (adult*)

Table 1
Characteristics of Studies that Examine the Impact of Emergency Intubation Using Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s), Study Design
Date

Location/
No. of EDs

Sample

Choi,
Kim et al.
2015

Prospective
Observational

Korea/44

Adult
patients
requiring
emergent
intubation

Lee et al.,
2016

Prospective
observational

Korea/22

Adult
patients
requiring
emergent
intubation

No. of
Intubations

DL
Attempts

VL
Attempts

4041

3501

540

921

479

442

Percent
Of
Trauma
Patients/
Medical
Included
226/540
41.8%
Trauma
VL;
791/3501
22.6% FL;
/1017/404
9 25.1%
combined
188/921
20.4%
Trauma
Combined

Participants
Excluded

Dates
Data
Collected

VL
Device

Provider

Cardiac arrest
cases

Jan 2007Dec 2010

GVL

EM
Residents
[Junior
(<=PGY3,
Senior(PGY
4&5)] and
Attendings

Surgical
methods and
extraglottic
devices were
used on first
intubation
attempt, or
the first
operator was
not EM
physician

Season
II*, Jan
2013-Dec
2015

GVL

EM
Residents
(PGY 1, 2,
3) and
Attendings
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Table 1 (continued)
Characteristics of Studies that Examine the Impact of Emergency Intubation Using Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s), Study Design
Date

Location/
No. of
EDs

Sample

Park et
al., 2015

Interrupted
time series
observational
cohort

Korea/22

Adults
out-ofhospital
cardiac
arrest
patients
requiring
emergent
intubatio
n
during
CPR in
ED

PlattsMills et
al., 2009

Prospective
observational

United
States/
1

Adult
patients
requiring
intubation

No. of
Intubations

DL
Attempts

VL
Attempts

83

34

49

280

217

63

Percent
of Trauma
Patients/
Medical
Included
UTD

(17/63 27%
Trauma
VL; 80/217
37%
Trauma
DL; 97/280
34.6%
Combined)

Participants
Excluded

Dates
Data
Collected

VL
Device

Provider

(1) “Do not
attempt CPR”
request (2)
Patients
intubated
before arrival
(3) Traumatic
arrest patients
wearing
cervical
collars, and
(4) First
attempt by
other
residents or
staff.

May
2011- Apr
2013

GVL

PGY1 &
PGY2 EM
Residents

Patients
intubated
before arrival

Aug 2006Feb 2008

GVL

EM
Residents
(PGY2,
PGY3,
PGY4)
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Table 1 (continued)
Characteristics of Studies that Examine the Impact of Emergency Intubation Using Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s), Study Design
Date

Location/
No. of
EDs

Sample

No. of
Intubations

DL
Attempts

VL
Attempts

Sakles et
al., 2017

Prospective
observational

United
States/1

Driver et
al. 2016

RCT

United
States/1

Percent
of Trauma
Patients/
Medical
Included

Participants
Excluded

Dates
Data
Collected

VL
Device

Provider

Adult
patients
requiring
emergent
intubation

1985

1035

950

(489/950
51.5% trauma
VL/ 332/1035
32.1% trauma
DL) 821/1985
41.4%
combined)

July 1,
2007June
2016

GVL

EM
Residents
[PGY 1, 2,
3(PGY
3,4,5)]
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UTD

Intubated
by Non-EM
Residents,
Non GVL
and NonDL; NonRSI,
Pediatrics
Pregnant or
a prisoner
or if the
treating
physician
planned an
approach
other than
DL on the
first
intubation
attempt.

Patients
requiring
emergent
intubation

198

106

Nov
2011Feb 2013

CMAC

PGY 2
Residents,
Senior EM
residents
(PGY3)
and
Attending
EM
Physicians
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Table 1 (continued)
Characteristics of Studies that Examine the Impact of Emergency Intubation Using Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s), Study Design
Date

Location/
No. of
EDs

Sample

No. of
Intubations

DL
Attempts

VL
Attempts

Goksu et
al., 2016

RCT

Turkey/1

Sulser et
al., 2016

RCT

Switzerlan
d/11

Percent
of Trauma
Patients/
Medical
Included

Participants
Excluded

Dates
Data
Collecte
d

VL
Device

Provider

Blunt
trauma
patients
requiring
emergent
intubation

150

75

75

100%
Trauma/ 0%
Medical

May
2013Oct
2013

CMAC

Residents
and
Attending
EM
physicians

74

(88/147 59.9%
Trauma;
59/147 40.1%
Medical)

Patients with
penetrating
trauma,
pediatrics or
intubated
before ED
arrival
Patients with
maxillofacial
trauma,
immobilized
cervical
spine, known
difficult
airway or
ongoing
cardiopulmonary
resuscitation

Patients
requiring
RSI

147

73

Nov
2014Dec
2015

CMAC

Experiencd
Anesthesia
Attendings
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Table 1 (continued)
Characteristics of Studies that Examine the Impact of Emergency Intubation Using Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s),
Date

Study Design

Location/
No. of EDs

Sample

Yeatts et
al., 2013

RCT

United
States/1

Trauma
patients
requiring
emergent
intubation

No. of
Intubations

DL
Attempts

VL
Attempts

623

320

303

Percent
of Trauma
Patients/
Medical
Included
100% Trauma/
0% Medical

Participants
Excluded

Dates
Data
Collected

VL
Device

Provider

Minors, pts.
w/suspected
laryngeal
trauma or
extensive
maxillofacial injury
requiring
immediate
surgical
airway,
known, or
strongly
suspected
spinal cord
injury for
whom awake
flexible
fiber-optic
intubation
was
indicated.
Patients in
cardiac arrest
on arrival
and those
who died in
the TRU

July 15,
2008May 15,
2010

GVL

Anesthesia
residents &
Attendings,
Critical
Care
residents,
Emergency
Medicine
residents,
Surgery
residents,
CRNAs,
SRNAs
(Not
reported
separately
by FPS)

Note. EM = emergency medicine specialty; PGY= post graduate year of medical education training; RSI= rapid sequence intubation; GVL = GlideScope;
CMAC=McGrath C-MAC; UTD= Unable to determine based on how data were reported. TRU = trauma resuscitation unit; GVL = GlideScope; CRNA =
certified Registered Nurse anesthetist; SRNA = student Registered Nurse anesthetist; FPS = first pass success.
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Table 2
First-Pass Intubation Success Rate (FPSR) and First Pass Attempts (FPA) for the Video Laryngoscope (VL) and Direct Laryngoscope (DL)
Author(s), Date
Choi, Kim et al., 2015
Lee et al., 2016
Park et al., 2015
Platts-Mills et al., 2009
Sakles et al., 2017
Driver et al., 2016
Goksu et al., 2016
Sulser et al., 2016
Yeatts et al., 2013
FPSR Mean

VL FPS
463
419
45
51
835
86
47
73
242

VL FPA
540
442
49
63
950
92
75
74
303

VL FPSR
85.74%
94.80%
91.84%
80.95%
87.89%
93.48%
62.67%
98.65%
79.87%
86.2%

DL FPS
2880
365
19
182
755
91
44
73
259

DL FPA
3501
479
34
217
1035
106
75
73
320

DL FPSR
82.26%
76.20%
55.88%
83.87%
72.95%
85.85%
58.67%
100.00%
80.94%
77.40%

FPSR Range

62.7%
98.6%

55.88%
100.00%

FPSR Median

87.89%

80.94%
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Table 3A
Risk of Bias for Observational Studies that Examined the Impact of Emergency Intubation using the Direct Laryngoscope (DL) Compared to the Video
Laryngoscope (VL)

Author(s),
Date
Choi et al.,
2015
Lee et al.,
2016
Park et al.,
2015
Platts-Mills
et al., 2009
Sakles et al.,
2017

Allocation
concealment
(selection bias)

Blinding of
participants and
personnel
(performance
bias)

Blinding of
outcome
assessment
(detection
bias)

Incomplete
outcome
data
(attrition
bias)

Selective
reporting
(reporting
bias)

Other bias

Appropriate
eligibility
criteria

Flawed
measurement
of both
exposure and
outcome

Failure to
adequately
control
confounding

High

High

High

Low

High

High

Unclear

High

Low

High

High

High

Unclear

High

High

Unclear

High

High

High

High

High

Low

Unclear

High

High

High

High

High

High

High

Unclear

High

High

Low

High

High

High

High

High

High

High

High

Unclear

High

Unclear

73

Table 3B
Risk of Bias for RCT Studies that Examined the Impact of Emergency Intubation Using the Direct Laryngoscope (DL) Compared to the Video Laryngoscope (VL)
Author(s), Date

Random sequence
generation
(selection bias)

Allocation
concealment
(selection bias)

Blinding of
participants and
personnel
(performance
bias)
High

Blinding of
outcome
assessment
(detection bias)

Incomplete
outcome data
(attrition bias)

Selective reporting
(reporting bias)

Driver et al.,
High
Low
High
Low
Unclear
2016
Goksu et al.,
Unclear
Low
High
High
Unclear
Unclear
2016
Sulser et al.,
High
Low
High
High
Unclear
Unclear
2016
Yeatts et al.,
Unclear
Low
High
High
High
Low
2013
Note. High= high risk of bias; Unclear= cannot determine risk based on evidence reported; Low= low risk of bias. RCT, randomized controlled trial.

Other
bias

High
High
High
High
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Figure 1. Flowchart of studies selected for the meta-analysis. Preferred reporting items for systematic reviews and meta-analyses (PRISMA)
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Figure 2. The pooled Odds Ratio (OR) is 1.89 [1.17, 3.07] with p-value <0.01 indicating a significantly
better effect for the VL than the DL. Significant heterogeneity (I2=88%) was found among the studies.
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Figure 3. The observational studies showed statistically significant effect of VL against DL with Odds
Ratio (OR) 2.49 [1.32, 4.71] with p-value < 0.01. There is high heterogeneity in the observational studies
(I2=91%) and low heterogeneity in the RCTs (I2=14%).
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Figure 4. In the subgroup analysis by VL device type the GlideScope (GVL) showed statistically
significant results of VL against DL with Odds Ratio 2.08[95% CI 1.17-3.73, p-< 0.01]. There was
homogeneity among the studies using the C-MAC device (I2=4%). GVL was a source of heterogeneity
(I2=92%).
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Figure 5. In the subgroup analysis by study location (studies conducted in the USA or those carried out
outside of the USA), no statistically significant results were found.
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.

Figure 6. The funnel plot is symmetrical for this meta-analysis. Although several studies are out of the
funnel shape, the Egger’s test found there is no publication bias (p-value = 0.9611). The Begg’s (1994) test
also found there is no publication bias (p-value = 0.6767).
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Figure 7. The trim-and-fill method was utilized by inputting the estimated values of the possible missing
data to assess of missing data bias. Only one replacement was needed on the right side of the funnel plot.
After the replacement, the pooled OR was 1.95 [95% CI 1.21-3.16, p = 0.0061], which did not alter the
pooled estimate of the main data OR of 1.89 [95% CI 1.16-3.07, p= 0.0098]. Again, these results indicate
there is no significant effect of the missing data for this meta-analysis
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Figure 8. Removes one study each time and measures the pooled estimate. Pooled estimates are calculated
omitting one study at a time to check the influence of the study.
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Box 2
Quality Assessment and Risk of Bias Tools

Cochrane Risk of Bias Tool for Randomized Controlled Trials
RANDOM SEQUENCE GENERATION
Selection bias (biased allocation to interventions) due to inadequate generation of a randomised
sequence.

Criteria for a judgment
of ‘Low risk’ of bias.

Criteria for the
judgment of ‘High
risk’ of bias.

Criteria for the
judgment of ‘Unclear
risk’ of bias.

The investigators describe a random component in the sequence generation
process such as:
• Referring to a random number table;
• Using a computer random number generator;
• Coin tossing;
• Shuffling cards or envelopes;
• Throwing dice;
• Drawing of lots;
• Minimization*.
*Minimization may be implemented without a random element, and this is
considered to be equivalent to being random.
The investigators describe a non-ra ndom component in the sequence
generation process. Usually, the description would involve some systematic,
non-random approach, for example:
• Sequence generated by odd or even date of birth;
• Sequence generated by some rule based on date (or day) of admission;
• Sequence generated by some rule based on hospital or clinic record
number.
Other non-random approaches happen much less frequently than the
systematic approaches mentioned above and tend to be obvious. They usually
involve judgement or some method of non-random categorization of
participants, for example:
• Allocation by judgement of the clinician;
• Allocation by preference of the participant;
• Allocation based on the results of a laboratory test or a series of tests;
• Allocation by availability of the intervention.
Insufficient information about the sequence generation process to permit
judgement of ‘Low risk’ or ‘High risk’.

•
•

Criteria for the
judgment of ‘Unclear
risk’ of bias.

(unless clear justification for their reporting is provided, such as an
unexpected adverse effect);
One or more outcomes of interest in the review are reported
incompletely so that they cannot be entered in a meta-analysis;
The study report fails to include results for a key outcome that would
be expected to have been reported for such a study.

Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’. It
is likely that the majorityE-9
of studies will fall into this category.
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ALLOCATION CONCEALMENT
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations
prior to assignment.

Criteria for a judgment
of ‘Low risk’ of bias.

Participants and investigators enrolling participants could not foresee
assignment because one of the following, or an equivalent method, was used
to conceal allocation:
• Central allocation (including telephone, web-based and pharmacycontrolled randomization);
• Sequentially numbered drug containers of identical appearance;
• Sequentially numbered, opaque, sealed envelopes.

Criteria for the
judgment of ‘High risk’
of bias.

Participants or investigators enrolling participants could possibly foresee
assignments and thus introduce selection bias, such as allocation based on:
• Using an open random allocation schedule (e.g. a list of random
numbers);
• Assignment envelopes were used without appropriate safeguards
(e.g. if envelopes were unsealed or non-opaque or not sequentially
numbered);
• Alternation or rotation;
• Date of birth;
• Case record number;
• Any other explicitly unconcealed procedure.

Criteria for the
judgment of ‘Unclear
risk’ of bias.

Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’.
This is usually the case if the method of concealment is not described or not
described in sufficient detail to allow a definite judgement – for example if
the use of assignment envelopes is described, but it remains unclear whether
envelopes were sequentially numbered, opaque and sealed.

SELECTIVE REPORTING
Reporting bias due to selective outcome reporting.

Criteria for a judgment
of ‘Low risk’ of bias.

Any of the following:
• The study protocol is available and all of the study’s pre-specified
(primary and secondary) outcomes that are of interest in the review
have been reported in the pre-specified way;
• The study protocol is not available but it is clear that the published
reports include all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon).

Criteria for the
judgment of ‘High risk’
of bias.

Any one of the following:
• Not all of the study’s pre-specified primary outcomes have been
reported;
• One or more primary outcomes is reported using measurements,
analysis methods or subsets of the data (e.g. subscales) that were not
pre-specified;
• One or more reported primary outcomes were not pre-specified
E-10
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Box 3
Risk of Bias
Tool to Assess Risk of Bias in Randomized Controlled Trials

1. Was the allocation sequence adequately generated?
Definitely yes
Probably yes
Probably no
(low risk of bias)

Definitely no
(high risk of bias)

Examples of low risk of bias: Referring to a random number table; Using a computer random
number generator; Coin tossing; Shuffling cards or envelopes; Throwing dice; Drawing of lots;
Minimization with or without a random element.

Examples of high risk of bias: Sequence generated by odd or even date of birth; Sequence
generated by some rule based on date (or day) of admission; Sequence generated by some rule
based on hospital or clinic record number; Allocation by judgment of the clinician; Allocation
by preference of the participant; Allocation based on the results of a laboratory test or a series
of tests; Allocation by availability of the intervention.

2. Was allocation adequately concealed?
Definitely yes
Probably yes
(low risk of bias)

Probably no

Definitely no
(high risk of bias)
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Examples of possible low risk of bias: Sequentially numbered drug containers of identical
appearance; Sequentially numbered, opaque, sealed envelopes.

Examples of high risk of bias allocation generation techniques: Using an open random
allocation schedule (e.g. a list of random numbers); Assignment envelopes were utilized
without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not
sequentially numbered); Alternation or rotation; Date of birth; Case record number; Any other
explicitly unconcealed procedure.

1. Blinding: Was knowledge of the allocated interventions adequately
prevented?
Definitely yes
Probably yes
Probably no
Definitely no
(low risk of bias)

(high risk of bias)

Examples of low risk of bias: No blinding, but the review authors judge that the outcome and
the outcome measurement are not likely to be influenced by lack of blinding; Blinding of
participants and key study personnel ensured, and unlikely that the blinding could have been
broken; Either participants or some key study personnel were not blinded, but outcome
assessment was blinded and the non-blinding of others unlikely to introduce bias.

Examples of high risk of bias: No blinding or incomplete blinding, and the outcome or
outcome measurement is likely to be influenced by lack of blinding; Blinding of key study
participants and personnel attempted, but likely that the blinding could have been broken;
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Either participants or some key study personnel were not blinded, and the non-blinding of
others likely to introduce bias.

3.a) Were patients blinded?
Definitely yes

Probably yes

Probably no

Definitely no

Probably no

Definitely no

Probably no

Definitely no

Probably no

Definitely no

Probably no

Definitely no

3.b). Were healthcare providers blinded?
Definitely yes

Probably yes

3.c). Were data collectors blinded?
Definitely yes

Probably yes

3.d). Were outcome assessors blinded?
Definitely yes

Probably yes

3.e). Were data analysts blinded?
Definitely yes

Probably yes

2. Was loss to follow-up (missing outcome data) infrequent?
Definitely yes
Probably yes
Probably no
Definitely no
(low risk of bias)

(high risk of bias)

Examples of low risk of bias: No missing outcome data; Reasons for missing outcome data
unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
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Examples of high risk of bias: Not all of the study’s pre-specified primary outcomes have been
reported; One or more primary outcomes are reported using measurements, analysis methods
or subsets of the data (e.g. subscales) that were not pre-specified; One or more reported
primary outcomes were not pre-specified (unless clear justification for their reporting is
provided,
such as an unexpected adverse effect); One or more outcomes of interest in the review are
incompletely reported so that they cannot be entered in a meta-analysis; The study report fails
to include results of a key outcome that would be expected to have been reported for such a
study
1. Was the study apparently free of other problems that could put it at a risk of
bias?
Definitely yes
Probably yes
Probably no
Definitely no
(low risk of bias)

(high risk of bias)

Examples of low risk of bias: The study appears to be free of other sources of bias.
Examples of high risk of bias: Had a potential source of bias related to the specific study
design used; Stopped early due to some data-dependent process (including a formal-stopping
rule); Had extreme baseline imbalance; Has been claimed to have been fraudulent; Had some
other problem.
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OTHER BIAS
Bias due to problems not covered elsewhere in the table.
Criteria for a judgment
of ‘Low risk’ of bias.

The study appears to be free of other sources of bias.

Criteria for the
judgment of ‘High risk’
of bias.

There is at least one important risk of bias. For example, the study:
• Had a potential source of bias related to the specific study design
used; or
• Has been claimed to have been fraudulent; or
• Had some other problem.

Criteria for the
judgment of ‘Unclear
risk’ of bias.

There may be a risk of bias, but there is either:
• Insufficient information to assess whether an important risk of bias
exists; or
• Insufficient rationale or evidence that an identified problem will
introduce bias.

BLINDING OF PARTICIPANTS AND PERSONNEL
Performance bias due to knowledge of the allocated interventions by participants and personnel
during the study.
Criteria for a judgment of Any one of the following:
‘Low risk’ of bias.
• No blinding or incomplete blinding, but the review authors judge
that the outcome is not likely to be influenced by lack of blinding;
• Blinding of participants and key study personnel ensured, and
unlikely that the blinding could have been broken.
Criteria for the judgment
of ‘High risk’ of bias.

Any one of the following:
• No blinding or incomplete blinding, and the outcome is likely to be
influenced by lack of blinding;
• Blinding of key study participants and personnel attempted, but
likely that the blinding could have been broken, and the outcome is
likely to be influenced by lack of blinding.

Criteria for the judgment
of ‘Unclear risk’ of bias.

Any one of the following:
• Insufficient information to permit judgment of ‘Low risk’ or ‘High
risk’;
• The study did not address this outcom e.
•

For continuous outcome data, plausible effect size (difference in
means or standardized difference in means) among missing
outcomes enough to induce clinically relevant bias in observed
effect size;
• ‘As-treated’ analysis done with substantial departure of the
intervention received from that assigned at randomization;
• Potentially inappropriate application of simple imputation.
Criteria for the
judgment of ‘Unclear
risk’ of bias.

Any one of the following:
• Insufficient reporting
E-12 of attrition/exclusions to permit judgement of
‘Low risk’ or ‘High risk’ (e.g. number randomized not stated, no
reasons for missing data provided);
• The study did not address this outcom e.

Thresholds for Converting the Cochrane Risk of Bias Tool to
AHRQ Standards (Good, Fair, and Poor)
Good quality: All criteria met (i.e. low for each domain)
Using the Cochrane ROB tool, it is possible for a criterion to be met even when the
element was technically not part of the method. For instance, a judgment that knowledge of the
allocated interventions was adequately prevented can be made even if the study was not blinded,
if EPC team members judge that the outcome and the outcome measurement are not likely to be
influenced by lack of blinding.
Fair quality: One criterion not met (i.e. high risk of bias for one domain) or two criteria unclear,
and the assessment that this was unlikely to have biased the outcome, and there is no known
important limitation that could invalidate the results
Poor quality: One criterion not met (i.e. high risk of bias for one domain) or two criteria
unclear, and the assessment that this was likely to have biased the outcome, and there are
important limitations that could invalidate the results
Poor quality: Two or more criteria listed as high or unclear risk of bias
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BLINDING OF OUTCOME ASSESSMENT
Detection bias due to knowledge of the allocated interventions by outcome assessors.
Criteria for a judgment
of ‘Low risk’ of bias.

Any one of the following:
• No blinding of outcome assessment, but the review authors judge
that the outcome measurement is not likely to be influenced by lack
of blinding;
• Blinding of outcome assessment ensured, and unlikely that the
blinding could have been broken.

Criteria for the
judgment of ‘High risk’
of bias.

Any one of the following:
• No blinding of outcome assessment, and the outcome measurement
is likely to be influenced by lack of blinding;
• Blinding of outcome assessment, but likely that the blinding could
have been broken, and the outcome measurement is likely to be
influenced by lack of blinding.

Criteria for the
judgment of ‘Unclear
risk’ of bias.

Any one of the following:
• Insufficient information to permit judgment of ‘Low risk’ or ‘High
risk’;
• The study did not address this outcom e.

INCOMPLETE OUTCOME DATA
Attrition bias due to amount, nature or handling of incomplete outcome data.
Criteria for a judgment
of ‘Low risk’ of bias.

Any one of the following:
• No missing outcome data;
• Reasons for missing outcome data unlikely to be related to true
outcome (for survival data, censoring unlikely to be introducing
bias);
• Missing outcome data balanced in numbers across intervention
groups, with similar reasons for missing data across groups;
• For dichotomous outcome data, the proportion of missing outcomes
compared with observed event risk not enough to have a clinically
relevant impact on the intervention effect estimate;
• For continuous outcome data, plausible effect size (difference in
means or standardized difference in means) among missing
outcomes not enough to have a clinically relevant impact on
observed effect size;
• Missing data have been imputed using appropriate methods.

Criteria for the
judgment of ‘High risk’
of bias.

Any one of the following:
• Reason for missing outcome data likely to be related to true
outcome, with either imbalance in numbers or reasons for missing
data across intervention groups;
• For dichotomous outcome data, the proportion of missing outcomes
compared with observed event risk enough to induce clinically
relevant bias in intervention effect estimate;
E-13
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Box 4
Quality Assessment and Risk of Bias Tool for Cohort Studies

Tool to Assess Risk of Bias in Cohort Studies

1. Was selection of exposed and non‐exposed cohorts drawn from the same population?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: Exposed and unexposed drawn for same administrative data base
of patients presenting at same points of care over the same time frame
Examples of high risk of bias: exposed and unexposed presenting to different points of care or
over a different time frame

2. Can we be confident in the assessment of exposure?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: Secure record [e.g. surgical records, pharmacy records]; Repeated
interview or other ascertainment asking about current use/exposure
Examples of higher risk of bias: Structured interview at a single point in time; Written self
report; Individuals who are asked to retrospectively confirm their exposure status may be
subject to recall bias – less likely to recall an exposure if they have not developed an adverse
outcome, and more likely to recall an exposure (whether an exposure occurred or not) if they
have developed an adverse outcome.
Examples of high risk of bias: uncertain how exposure information obtained

3. Can we be confident that the outcome of interest was not present at start of study
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

1
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4. Did the study match exposed and unexposed for all variables that are associated with the
outcome of interest or did the statistical analysis adjust for these prognostic variables?
Definitely yes
(low risk of bias)

Mostly yes

Mostly no

Definitely no
(high risk of bias)

Examples of low risk of bias: comprehensive matching or adjustment for all plausible prognostic
variables
Examples of higher risk of bias: matching or adjustment for most plausible prognostic variables
Examples of high risk of bias: matching or adjustment for a minority of plausible prognostic
variables, or no matching or adjustment at all. Statements of no differences between groups or
that differences were not statistically significant are not sufficient for establishing
comparability.

5. Can we be confident in the assessment of the presence or absence of prognostic factors?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: Interview of all participants; self‐completed survey from all
participants; review of charts with reproducibility demonstrated; from data base with
documentation of accuracy of abstraction of prognostic data
Examples of higher risk of bias: Chart review without demonstration of reproducibility; data
base with uncertain quality of abstraction of prognostic information
Examples of high risk of bias: Prognostic information from data base with no available
documentation of quality of abstraction of prognostic variables

2
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6. Can we be confident in the assessment of outcome?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: Independent blind assessment; Record linkage; For some
outcomes (e.g. fractured hip), reference to the medical record is sufficient to satisfy the
requirement for confirmation of the fracture.
Examples of higher risk of bias: Independent assessment unblinded; self‐report; For some
outcomes (e.g. vertebral fracture where reference to x‐rays would be required) reference to
the medical record would not be adequate outcomes.
Examples of high risk of bias: uncertain (no description)

7. Was the follow up of cohorts adequate?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: No missing outcome data; Reasons for missing outcome data
unlikely to be related to true outcome (for survival data, censoring is unlikely to introduce bias);
Missing outcome data balanced in numbers across intervention groups, with similar reasons for
missing data across groups; For dichotomous outcome data, the proportion of missing
outcomes compared with observed event risk is not enough to have a important impact on the
intervention effect estimate; For continuous outcome data, plausible effect size (difference in
means or standardized difference in means) among missing outcomes is not large enough to
have an important impact on the observed effect size; Missing data have been imputed using
appropriate methods.
Examples of high risk of bias: Reason for missing outcome data likely to be related to true
outcome, with either imbalance in numbers or reasons for missing data across intervention
groups; For dichotomous outcome data, the proportion of missing outcomes compared with
observed event risk is enough to induce important bias in intervention effect estimate; For
continuous outcome data, plausible effect size (difference in means or standardized difference
in means) among missing outcomes is large enough to induce clinically relevant bias in the
observed effect size.
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8. Were co‐Interventions similar between groups?
Definitely yes
(low risk of bias)

Probably yes

Probably no

Definitely no
(high risk of bias)

Examples of low risk of bias: Most or all relevant co‐interventions that might influence the
outcome of interest are documented to be similar in the exposed and unexposed.
Examples of high risk of bias: Few or no relevant co‐interventions that might influence the
outcome of interest are documented to be similar in the exposed and unexposed.

4
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Committees at 713-500-7943.

105

Appendix B
Approval Baylor College of Medicine IRB
7/19/2017

Human Approval Letter

September 12, 2016

MICHAEL GONZALEZ
BAYLOR COLLEGE OF MEDICINE
MEDICINE: EMERGENCY MEDICINE

Baylor College of Medicine
Office of Research
One Baylor Plaza, 600D
Houston, Texas 77030
Phone: (713) 798-6970
Fax: (713) 798-6990
Email: irb@bcm.tmc.edu

H39327  COMPARATIVE AND COST EFFETIVENESS ANALYSIS OF THE VIDEO LARYNGOSCOPE
APPROVAL VALID FROM 9/12/2016 TO 9/11/2017
Dear Dr. GONZALEZ
The Institutional Review Board for Human Subject Research for Baylor College of Medicine and Affiliated Hospitals (BCM
IRB) is pleased to inform you that the research protocol named above was reviewed and approved by Expedited
procedures on 9/12/2016 by Board 3.
The study may not continue after the approval period without additional IRB review and approval for continuation. You will
receive an email renewal reminder notice prior to study expiration; however, it is your responsibility to assure that this study
is not conducted beyond the expiration date.
Please be aware that only IRBapproved informed consent forms may be used when written informed consent is required.
Any changes in study or informed consent procedure must receive review and approval prior to implementation unless the
change is necessary for the safety of subjects. In addition, you must inform the IRB of adverse events encountered during
the study or of any new and significant information that may impact a research participants' safety or willingness to
continue in your study.
The BCM IRB is organized, operates, and is registered with the United States Office for Human Research Protections
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Appendix D
Study Operations Procedures
Study Protocol
The PICOS format was used for the research question to be consistent with
studies in the literature: Among adults emergently intubated in the Emergency
Department, does Video Laryngoscopy (VL) have a higher first pass success rate
compared with Direct Laryngoscopy (DL)?
i. Population- is Adults emergently intubated
ii. Intervention- is Video laryngoscopy
iii. Control- is Direct laryngoscopy
iv. Outcome- is the first pass success rate
v. Setting- is the Emergency Department
The inclusion and exclusion criteria are defined as:
Inclusion criteria (must include all of the following:
1. Compare FPS between VL and DL
2. Patients orotracheally intubated
3. ED patients
4. Adult patients (≧18 years old)
Exclusion criteria (any one of the following)
1. Manikin studies
2. Simulations
3. Case reports
4. Reviews
5. Pilot studies
6. Pediatrics
7. Intubation performed Outside ED (e.g., OR, ICU, or pre-hospital)
8. other types of intubations (e.g., nasotracheal)
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Search Strategy
1. Using terms from relevant documents and previous systematic reviews (see
Appendix Electronic Database Search Strategy for search terms)
2. The main search was conducted in Ovid Medline database using terms mapped to
subject heading in addition to the title, abstract and keyword searches.
3. The search strategy was then translated into the Cochrane Library database,
Embase, and Google Scholar.
4. The Google Scholar search was limited to the first one hundred articles retrieved
sorted by relevancy (see Appendix Electronic Database Search Strategy)
De-Duplication
1. Import database search results into citation reference manager (e.g. Endnote,
Refworks, Mendeley)
2. If using Endnote, open Endnote software, select “Import.”
3. A pop-up screen will appear with the files you have saved in the database search
results.
4. Select the file that the search was saved in, and click on the “Import” icon on the
bottom right side of the pop-up screen
5. Repeat will all database search results.
6. Once all database search results have been imported, select the References tab on
the tool bar.
7. Scroll down to “Find Duplicates” and hit enter.
8. Duplicate records will be displayed.
9. Record number of duplicates found.
10. Click on delete duplicates.
Rayyan Online Systematic Review Tool
1. Go to https:rayyan.qcri.org
2. Click on the “SIGN UP” icon
3. Fill in Sign up form, which includes email, title, first name, last name,
organization, position, country, and the reason for joining (all fields must be filled
in).
4. Click on “Sign up” icon at the bottom of the form.
5. Establish an account for all collaborators; each individual must sign up for an
individual account.
6. The owner of the review (called creator of the review) invites collaborators.
7. The creator of the review invites other reviewer(s) by sending email from Rayyan to
join in the review.
8. Each reviewer will fill in sign up form (as done in step 5a-d)
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9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.

26.
27.
28.

Click on the hyperlink “Check your browser compatibility” at the bottom of the
Rayyan sign on screen.
Create a new review by selecting "New review..." from the Rayyan home screen.
Blinding is turned on by the creator of the review by selecting the setting (Blind
OFF/ON) to “ON.”
Before importing records into Rayyan, perform de-duplication process by using
citation manager (e.g. Endnote, Refworks, Mendeley)
After de-duplication is performed, search results from search strategy will be
imported to Rayyan from individual databases.
Import search results from search strategy into Rayyan from individual
databases.
Import can be done with the following text formats: EndNote Export
(.enw), RIS, CSV and PubMed XML.
If using Endnote, click on the file tab, scroll down, and select “Export.”
An Export File Name pop-up window will appear
Select the file as type “Text Only.”
Output Style should be “Select Another Style…”
A Choose A Style pop-up window will appear
Select Export
Under Name of Style, highlight the Endnote Export Category then hit the
“Choose” icon
Another Export File Name pop-up window will appear, select “Save.”
If any duplicates are detected in Rayyan, a square icon will appear next to each
record as a possible duplicate.
If possible duplicate, select the record, "possible duplicate" tag will appear as
well as the option to accept the duplicate and delete it, or reject it and keep it as a
separate record.
Select option to delete record if it is a duplicate
If the record is not a duplicate, select reject and the record will be kept.
If the record is deleted in error, select the 'undo' option to undelete the record.

Screening
1. Use the inclusion criteria to label record as “include” if they met all of the
inclusion criteria:
a. Compare intubation first pass attempt success between VL and DL
b. Patients orotracheally intubated
c. ED patients
d. Adult patients (≧18)
2. If any of terms in the exclusion criteria are found in the study, then exclude with a
reason
3. The exclusion criteria included are:
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4.
5.
6.

7.
8.
9.

a. Manikin studies
b. Simulations
c. Case reports
d. Reviews
e. Pilot studies
f. Pediatrics
g. Intubation performed Outside ED (e.g., OR, ICU, or pre-hospital)
h. Other types of intubations (e.g., nasotracheal)
Reason and Label can be input by typing the reason or label into the “Reason” or
“Label) box to the right of the “Include” or “Exclude” icons
If the reviewer cannot decide whether an article should be included or excluded,
click “Undecided.”
When reviewers agreed that all articles had been reviewed, then Blinding is
turned off by the creator of review by selecting the setting (Blind OFF/ON) to
“Off.”
Articles not agreed on are listed as “conflict.”
Discussed articles where there was disagreement and decided if the study should
be included or excluded from the review.
If the conflict cannot be resolved, have an objective party be the deciding vote.

Data Extraction
1. Using the studies included in the review of the data, input into Excel spreadsheet
(Provide sample data log)
2. Data to be abstracted includes:
• Title of Study
• Purpose of Study
• Study Design
• Sample Size
• Location study was performed
• Setting
• Dates Collected
• Participants included
• Participants excluded
• Intervention
• Bias
• Study Size
• Quantitative variables
• Statistical Methods
• Outcomes
• Outcome: Definition and How Measured
• DL First Pass Success, * mandatory for inclusion
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• VL First Pass Success, * mandatory for inclusion
• Success in ≤ 3 Attempts
• DL Overall Success,
• VL Overall Success,
• VL utilized
• N
• Difficult Airway Characteristics listed
• Instrument used to identify difficult airway
• Adverse Events Reported
• Training received by intubators on VL and DL
• Key Results listed in study
• Limitations listed in study
• Generalizability
• Funding
• Comment
• Other
3. Evaluate studies to see if dates of data collected overlaps, if any studies overlap
that use the same database, keep only the most recent study.
Quality Assessment
Assess the quality of study design and risk of bias:
1. Use the Cochrane Collaboration tools for randomized controlled trials (RCTs) and
cohort studies (see Box 3 and 4)
2. Answer the questions for selection bias by assessing by evaluating adequacy of
random sequence generation and allocation concealment (see examples of low
risk and examples of high risk).
3. RCTs and observational studies are assessed for Selection, performance,
detection, attrition, reporting and other sources (the top six domains)
4. Observational studies are also assessed for potential confounding variables that
may impact the observed effect which include: eligibility criteria, intervention
administration and outcomes reported by the intubator.
5. If study follows is low risk then label “low risk”. If study is high risk then label
“high risk”. If it cannot be determined if study is high risk or low risk then label,
unknown.
6. After all studies have been evaluated, compare findings with another evaluator to
ensure no potential bias has been introduced.
7. Discusses articles where there was disagreement and decide if the domain should
be “low, high or unknown”.
8. If the conflict cannot be resolved, have an objective party be the deciding vote.
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Data Analysis were initially conducted by PI in RevMan 5.
Constructing a comparison table:
1. Add a comparison
2. Right-click the Data and Analyses heading in the outline and choose Add
Comparison. The New Comparison Wizard opens.
3. Enter a Name for the comparison (VL versus DL)
4. Type in the name, or base the name on that of an existing comparison.
To do so:
 Click the down arrow at the end of the Name box to open a pull-down list
of all comparisons.
 Choose the comparison you wish to base the name on.
 Edit the name.
5. Click Finish.
6. Other ways of adding a comparison:
 Click the Data and Analyses heading in the outline, and then click the Add
button on the toolbar.
 Click the Add Comparison button in the Data and analyses section in the Text
of Review.
Outcomes:
1. Add an outcome
2. Right- click the relevant comparison in the outline and choose Add Outcome.
3. The New Outcome Wizard opens.
4. Choose the data type for the outcome, and click Next.
5. Enter a Name for the outcome (first pass success)
6. Edit the Group Labels, and click Next.
7. Specify the analysis method, and click Next.
8. Specify the analysis details, and click Next.
9. Specify the graphs details, and click Next.
10. Choose the next action, and click Finish.
11. Once you have created an outcome, you can change the details of the analysis by
modifying the properties of the outcome. See Outcome properties.
Subgroups:
1.
2.
3.
4.

Add a subgroup
Right-click the relevant outcome in the outline and choose Add Subgroup.
The New Subgroup Wizard opens.
Enter a Name for the Subgroup.
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5. type in the name, or use the name of an existing subgroup.
6. To do so:
a. Click the down arrow at the end of the Name box to open a pull-down list
of all subgroups.
7. Choose the subgroup name you wish to use. You can edit the name, if necessary.
8. Click Finish.
Comparison properties:
1.
2.
3.
4.

Use the comparison properties window to modify:
The name of the comparison.
The group labels used in all outcomes for that comparison.
To change the group labels for all outcomes for a comparison - Open the outcome
properties
5. Click the outcome and the click the Properties button in the outline toolbar.
6. Select Set Group Labels for all Outcomes.
7. Enter the labels you wish to use.
8. Note: Even if you only wish to modify one of the labels, you must fill in both in
Group Label 1(VL) and Group Label 2 (DL). If you leave one blank, this would
be applied to all outcomes.
9. Click OK.
10. The new labels are applied to all outcomes for that comparison.
11. Use the outcome Name to describe the outcome (FPS)
12. Choose the following Data type:
13. Dichotomous: number of events and participants in the two groups.
14. The Group Labels (VL and DL) are used as headings in the data tables, and are
published on those analyses graphs that are included as figures. The default labels
are 'Experimental' and 'Control'. You can edit the labels for an individual outcome
on the outcome properties, but you can also change the labels used in all
outcomes for a comparison, see Comparison properties.
Entering data:
1. To enter data for a study, you must first have added the study to an analysis. Data
can be either typed in
2. or pasted in, e.g. from a spreadsheet.
3. As you enter data, these are dynamically updated in the Analysis graph.
4. To open a data table5. Click the outcome you wish to enter data for.
6. Click the Edit Outcome button on the outline toolbar.
7. The outcome data table and analysis will open in a new tab.
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Calculating data:
The calculator tool can assist you with data imputation and obtaining suitable data for
meta-analysis.
1. To calculate data- Open an Outcome tab and click a study.
2. 2.Click the calculator icon
3. The calculator window opens. Any study data already entered is used in the
corresponding fields.
4.
5. For Dichotomous and Inverse variance outcomes, select the statistical methods to
show.
6. Enter the data you have.
7. If the number you enter is valid, the background in the cell is green, but if there is
an error in the data, the background is red.
Funnel plots:
To view a funnel plot for an outcome
1.Open the data table for the outcome FPS
2.Click the Funnel Plot button.
The funnel plot opens in a new window.
Sensitivity analysis:
1. To perform sensitivity analysis, one can temporarily omit some of the studies
used in an outcome or subgroup from the analysis. Such exclusions will be stored
in the review file while you are working on it, but you cannot submit a review for
publication if studies have been omitted from analysis.
Note:
Analyses included as figures are automatically updated, so if studies are
temporarily omitted this will be reflected in the figures.
To omit a study:
1. Click the check box in front of the study name.
The check mark is removed, and the study no longer contributes to the analysis.
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To convert data into R, please see
https://cran.r-project.org/web/packages/meta/meta.pdf
Under Details (page 3):
1. Import data from ’RevMan 5’ (read.rm5; see also metacr)
2. Follow steps on p. 128
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